-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VzHObAzO9AOL272Pr5SjtFAU0ERATblOoMcFfj6XvqoZrRhUjJN/ZYBGTTr04rD0 2KQr1R1rwQ+j88Mogg2Vlg== 0000950144-02-005181.txt : 20020513 0000950144-02-005181.hdr.sgml : 20020513 ACCESSION NUMBER: 0000950144-02-005181 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20020513 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE ONCOLOGY INC CENTRAL INDEX KEY: 0000763098 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621212264 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09922 FILM NUMBER: 02643115 BUSINESS ADDRESS: STREET 1: 1775 MORIAH WOODS BLVD CITY: MEMPHIS STATE: TN ZIP: 38117 BUSINESS PHONE: 9017617000 MAIL ADDRESS: STREET 1: 1775 MORIAH WOODS BLVD CITY: MEMPHIS STATE: TN ZIP: 38117 FORMER COMPANY: FORMER CONFORMED NAME: BIOTHERAPEUTICS INC DATE OF NAME CHANGE: 19891221 FORMER COMPANY: FORMER CONFORMED NAME: RESPONSE TECHNOLOGIES INC DATE OF NAME CHANGE: 19920703 8-K 1 g76164e8-k.txt RESPONSE ONCOLOGY, INC. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------------- FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 13, 2002 ------------------------------- Response Oncology, Inc. ---------------------------- (Exact name of registrant as specified in its charter) State of Tennessee 0-15416 62-1212264 - --------------------------- -------- -------------------- (State or other jurisdiction (Commission File No.) (I.R.S. Employer of incorporation or organization) Identification No.) 1805 Moriah Woods Blvd. Memphis, Tennessee 38117 --------------------------- (Address of Principal Executive Offices) (901) 761-7000 ------------------------------- (Registrant's telephone number, including area code) Item 5. Other Events. On May 10, 2002, Response Oncology, Inc. and its wholly owned subsidiaries (Response Oncology Management of South Florida, Inc., Response Oncology of Fort Lauderdale, Inc. and Response Oncology of Tamarac, Inc.) (the "Company" or the "Debtors") issued a press release announcing that the United States Bankruptcy Court for the Western District of Tennessee, Western Division (the "Court"), approved a disclosure statement filed in connection with the Joint Plan filed by the Debtors and AmSouth Bank, as agent for itself, Bank of America, N.A. and Union Planters Bank, N.A. on Friday, May 3, 2002. The press release is attached as Exhibit 99.1 to this Form 8-K. On May 9, 2002, the Company filed its monthly operating reports for the month of February 2002 with the Court, a copy of which is filed herewith as Exhibit 99.2 to this Form 8-K. The carrying value of certain assets of the Company (principally intangible assets) as of December 31, 2001, are subject to material adjustments pending finalization of various sales transactions that recently closed and completion of the Company's audit. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (c) Exhibits 99.1 Response Oncology, Inc. Press Release issued May 10, 2002. 99.2 Chapter 11 Monthly Operating Reports for February 2002 filed on May 9, 2002 by Response Oncology, Inc., Response Oncology Management of South Florida, Inc., Response Oncology of Fort Lauderdale, Inc. and Response Oncology of Tamarac, Inc., debtors-in-possession in Chapter 11 case number 01-24607-DSK (jointly administered) in the United States Bankruptcy Court for the Western District of Tennessee, Western Division, in Memphis, Tennessee. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Response Oncology, Inc. By: /s/ Peter A. Stark Date: May 13, 2002 ---------------------------------------- Peter A. Stark, Executive Vice President, Chief Financial Officer EXHIBIT INDEX
Exhibit Number Description 99.1 Response Oncology, Inc. Press Release issued May 10, 2002. 99.2 Chapter 11 Monthly Operating Reports for February 2002 filed on May 9, 2002 by Response Oncology, Inc., Response Oncology Management of South Florida, Inc., Response Oncology of Fort Lauderdale, Inc. and Response Oncology of Tamarac, Inc., debtors-in-possession in Chapter 11 case number 01-24607-DSK (jointly administered) in the United States Bankruptcy Court for the Western District of Tennessee, Western Division, in Memphis, Tennessee.
EX-99.1 3 g76164ex99-1.txt PRESS RELEASE EXHIBIT 99.1 NEWS (FRB LOGO) RE: RESPONSE ONCOLOGY, INC. 1805 MORIAH WOODS BLVD. MEMPHIS, TN 38117 (901) 761-7000 OTCBB: ROIXE FOR YOUR INFORMATION: AT THE COMPANY: AT FRB | WEBER SHANDWICK Charles E. Sweet Marilyn Windsor Leslie Loyet Cynthia Martin President & Chief Executive Officer General Information Analysts/Investors Media Inquiries (800) 323-3719 (702) 515-1260 (312) 640-6672 (312) 640-6741 csweet@responseoncology.com mwindsor@webershandwick.com lloyet@webershandwick.com clmartin@webershandwick.com
FOR IMMEDIATE RELEASE FRIDAY, MAY 10, 2002 RESPONSE ONCOLOGY FILES PLAN, COURT APPROVES DISCLOSURE STATEMENT MEMPHIS, TN--MAY 10, 2002--RESPONSE ONCOLOGY, INC., (OTCBB: ROIXE) and its affiliated entities (collectively "ROI" or the "Company"), today announced that the United States Bankruptcy Court for the Western District of Tennessee, Western Division (the "Court") approved a disclosure statement (the "Disclosure Statement") filed in connection with the Joint Plan (the "Plan") filed by ROI and AmSouth Bank, as agent for itself, Bank of America, N.A. and Union Planters Bank, N.A. (the "Lenders") on Friday, May 3, 2002. Under the Plan, originally filed April 12, 2002, and amended April 19, 2002, ROI's outstanding common stock, preferred stock, options and warrants will be cancelled and current shareholders and warrantholders will not receive any consideration. The Company has liquidated substantially all of its assets and will complete the process of liquidating all of its assets this summer. Under the Plan, the Lenders, whose outstanding secured claim was allowed in the amount of $29,545,087.31 by Court order dated October 26, 2001, will be paid all proceeds from the liquidation, except for amounts to be paid on account of allowed administrative and priority claims (estimated to be approximately $3,500,000), and $250,000, which will be distributed to general unsecured creditors. The liquidation of ROI's assets will not return to the Lenders or general unsecured creditors the full amount of their claims. The Court has set a hearing on the confirmation of the Plan for June 14, 2002 at 11:00 a.m. CDT. If the Plan is confirmed, upon completion of the liquidation of all ROI's assets and distribution of those proceeds, the Company will be dissolved. Creditors and other parties in interest wishing to obtain a copy of the Plan and Disclosure Statement may go to www.wallerlaw.com. In addition, the Plan, as well as the Disclosure Statement, are on file with the Court and are available for review and copying during the Court's normal business hours. MORE RESPONSE ONCOLOGY, INC. ADD 1 On April 24, 2002, pursuant to the Court's order extending permission for ROI to use cash collateral and to make certain bonus and severance payments (the "Cash Collateral Order"), Anthony LaMacchia, ROI's chief executive officer and a member of ROI's board of directors (the "Board") resigned, along with all other then-existing members of the Board. Charles E. Sweet replaced Mr. LaMacchia as CEO and also serves as chairman of the Board. Peter A. Stark, ROI's chief financial officer, and James A. Skinner filled the other Board positions, pursuant to the Court's Cash Collateral Order. The Board has directed ROI to complete the audit of its 2001 consolidated financial statements. Subject to the timing of the completion of the audit, ROI will file its Form 10-K as of and for the year ended December 31, 2001, and its first quarter Form 10-Q for the quarter ended March 31, 2002, with the Securities and Exchange Commission ("SEC"). The Company anticipates that these filings will be submitted within the next 45-60 days. Next week, the Company will also be filing a Form 8-K with the SEC that contains this press release and its February 2002 unaudited monthly operating report. Management has included herein certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. When used, statements which are not historical in nature including the words "anticipate," "estimate," "should," "expect," "believe," "intend," and similar expressions are intended to identify forward-looking statements. Forward-looking statements are, by their nature, subject to known and unknown risks and uncertainties. Forward-looking statements include statements about the Plan and its confirmation, the timing of completion of ROI's liquidation, the timing of completion of ROI's audit and the filing of periodic reports with the SEC. These statements are based on current expectations and the current status of ROI's financial condition and filings with the Court. They involve a number of risks and uncertainties that are difficult to predict, including, but not limited to: the ability of ROI to liquidate its assets under the terms of the Plan as filed with the Court; confirmation of the Plan by the Court and approval by the creditors; the ability of ROI's independent auditors to complete their audit of ROI's financial statements for the year ended December 31, 2001 and review of ROI's financial statements for the quarter ended March 31, 2002 based on information available to them; and the ability of current management of ROI to complete the filings of its Form 10-K and the Form 10-Q described herein based on information available to them. Actual results could differ materially from those expressed or implied in the forward-looking statements. Important assumptions and other important factors, risks, and uncertainties that could cause actual results to differ materially from those in the forward-looking statements included in this release are detailed from time to time in other press releases and reports filed by ROI with the SEC, including Forms 8-K, 10-Q and 10-K. ROI assumes no obligation to publicly release any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. ### EX-99.2 4 g76164ex99-2.txt CHAPTER 11 MONTHLY OPERATING REPORTS EXHIBIT 99.2 MONTHLY OPERATING REPORT COVER SHEET, CHECKLIST, & CERTIFICATE OF SERVICE UNITED STATES BANKRUPTCY COURT WESTERN DISTRICT OF TENNESSEE Case No.: 01-24607-DSK In re: RESPONSE ONCOLOGY, INC., et al. ------------- ------------------------------- Judge: David S. Kennedy ---------------- Debtor(s) Chapter 11 MONTHLY OPERATING REPORT FOR MONTH ENDING February 28, 2002 COME(S) NOW, RESPONSE ONCOLOGY, INC., et al. Debtor-In-Possession, and hereby submits its Monthly Operating Report for the period commencing February 1 and ending February 28 as shown by the report and exhibits consisting of 35 pages and containing the following as indicated: X Monthly Reporting Questionnaire (Attachment 1) --- X Comparative Balance Sheets (Forms OPR-1 & OPR-2) --- X Summary of Accounts Receivable (Form OPR-3) --- X Schedule of Postpetition Liabilities (Form OPR-4) --- X Statement of Income (Loss) (Form OPR-5) --- X Statement of Sources and Uses of Cash (Form OPR-6) --- X Certificate of Service --- ACCOUNTING METHOD USED: Cash --- X Accrual --- I declare under penalty of perjury that this Report and all attachments are true and correct to the best of my knowledge and belief. I also hereby certify that the original Monthly Operating Report was filed with the Bankruptcy Court Clerk and a file stamped copy delivered to the U.S. Trustee. Date: May 8, 2002 ----------- DEBTOR-IN-POSSESSION By: /s/ Peter A. Stark ---------------------------------------- (Signature) Name & Title: Peter A. Stark, CFO ----------------------------- (Print or Type) Address: 1805 Moriah Woods Blvd. ---------------------------------- Memphis, TN 38117 -------------------------------------------- Telephone Number: (901) 761-7000 --------------------------- REV 7/99 ATTACHMENT 1 (PAGE 1 of 4) CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: RESPONSE ONCOLOGY, INC., et al. --------------------------------------------- CASE NUMBER: 01-24607-DSK ------------------------------------------- MONTH OF: February 2002 ---------------------------------------------- 1. PAYROLL State the amount of all executive wages paid and taxes withheld and paid.
WAGES PAID TAXES ---------------------- ---------------------------- NAME AND TITLE OF EXECUTIVE GROSS NET AMOUNT DUE PAID - --------------------------- ------- ------- ------------ ---------- See Schedule 1 attached. - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- Total Executive Payroll: ----------------------------------------------------------------------
2. INSURANCE Is workers' compensation and other insurance in effect? YES Are payments current? YES If any policy has lapsed, been replaced or renewed, so state in the schedule below. Attach a copy of the new policy's binder or cover page.
DATE COVERAGE EXPIRATION PREMIUM COVERAGE TYPE NAME OF CARRIER AMOUNT POLICY # DATE AMOUNT PD. THRU - ---- --------------- -------- -------- ---------- ------- -------- Casualty See Schedule 2 attached. ------------------------------------------------------------------------------------------------------------ Workers' comp. ------------------------------------------------------------------------------------------------------- General liab. ------------------------------------------------------------------------------------------------------- Vehicle -------------------------------------------------------------------------------------------------------------- Other (specify): ----------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------- REV 7/99
ATTACHMENT 1 (PAGE 2 of 4) CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: RESPONSE ONCOLOGY, INC., et al. ---------------------------------------------------- CASE NUMBER: 01-24607-DSK -------------------------------------------------- MONTH OF: February, 2002 ----------------------------------------------------- 3. Bank Accounts
Account Type --------------------------------------------------------------------- Operating Tax Payroll Other Total --------- --------- --------- --------- --------- Bank name See Schedule 3 attached. --------- --------- --------- --------- Account # --------- --------- --------- --------- Beginning book balance --------- --------- --------- --------- --------- Plus: Deposits (Attach detailed listing) --------- --------- --------- --------- --------- Less: Disbursements (Attach detailed listing) --------- --------- --------- --------- --------- Other: Transfers In (Out) ----0---- --------- --------- --------- --------- --------- Ending book balance --------- --------- --------- --------- ---------
4. Postpetition Payments. List any postpetition payments to professionals and payments on prepetition debts in the schedule below (attach a separate sheet if necessary).
Payments To/On Amount Date Check # Court Order Date - -------------- --------- --------- --------- ---------------- Professionals (attorneys, accountants, etc.): See Schedule 4 attached. - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- Prepetition debts: See Schedule 4 attached. - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ----------------
REV 7/99 ATTACHMENT 1 (PAGE 3 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF RECEIPTS CASE NAME: RESPONSE ONCOLOGY, INC., et al. -------------------------------------------- CASE NUMBER: 01-24607-DSK ------------------------------------------ MONTH OF: February, 2002 -------------------------------------------- BANK NAME: ACCOUNT #: ------------------------- ------------------------- Detail of Receipts:
Date Received From Explanation Amount - --------- -------------------------- -------------------------- -------------------------- See "Detailed Listing of Receipts" Schedule attached. - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- Total Receipts *Must agree to "Deposits" line of Item 3 on Attachment 1 (Page 2). -------------------------- REV 7/99 (attach additional sheets if necessary)
ATTACHMENT 1 (PAGE 4 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF DISBURSEMENTS CASE NAME: RESPONSE ONCOLOGY, INC. et. al. ---------------------------------------------- CASE NUMBER: 01-24607-DSK -------------------------------------------- MONTH OF: February 2002 ----------------------------------------------- BANK NAME: ACCOUNT #: -------------------------- -------------------------------- Detail of Disbursements:
Date Check # Paid To/In Payment Of Amount - --------- ---------- ------------------------------- ---------- See "Detailed Listing of Disbursements" Schedule attached. - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ----------
Total Disbursements *Must agree to "Disbursements" line of Item --------------- 3 on Attachment 1 (Page 2). REV 7/99 (attach additional sheets if necessary) CASE NAME: RESPONSE ONCOLOGY, COMPARATIVE BALANCE SHEETS FORM OPR-1 -------------------- INC., et. al. REV 7/99 -------------------- CASE NUMBER: 01-24607-DSK MONTH ENDED: February, 2002 ------------- ---------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------ ----- ----- ----- ----- ----- ----- ASSETS CURRENT ASSETS Cash See "Comparative Balance Sheets" attached. ----- ----- ----- ----- ----- ----- ----- Other negotiable instruments (i.e. CD's, Treasury bills, etc.) ----- ----- ----- ----- ----- ----- ----- Accounts receivable, net (See OPR-3) ----- ----- ----- ----- ----- ----- ----- Less allowance for doubtful accounts ----- ----- ----- ----- ----- ----- ----- Inventory, at lower of cost of market ----- ----- ----- ----- ----- ----- ----- Prepaid expenses and deposits ----- ----- ----- ----- ----- ----- ----- Investments ----- ----- ----- ----- ----- ----- ----- Other ------------------------------------ ----- ----- ----- ----- ----- ----- ----- TOTAL CURRENT ASSETS ----- ----- ----- ----- ----- ----- ----- PROPERTY, PLANT & EQUIPMENT AT COST ----- ----- ----- ----- ----- ----- ----- Less accumulated depreciation ----- ----- ----- ----- ----- ----- ----- NET PROPERTY, PLANT & EQUIPMENT ----- ----- ----- ----- ----- ----- ----- OTHER ASSETS ----- ----- ----- ----- ----- ----- ----- - ------------------------------------------- ----- ----- ----- ----- ----- ----- ----- TOTAL ASSETS ----- ----- ----- ----- ----- ----- -----
* Itemize on separate page if value of "Other Assets" exceeds 10% of "Total Assets". CASE NAME: RESPONSE ONCOLOGY, INC., et al COMPARATIVE BALANCE SHEETS ------------------------------- FORM OPR-2 CASE NUMBER: 01-24607-DSK MONTH ENDED: February, 2002 REV 7/99 ----------------------------- -----------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------------ --------- --------- --------- --------- --------- --------- LIABILITIES POST PETITION LIABILITIES (See OPR-4) -0- See "Comparative Balance Sheets" attached. --------- --------- --------- --------- --------- --------- PRE PETITION LIABILITIES Secured debt (petition Schedule D) ------------ --------- --------- --------- --------- --------- --------- Priority debt (petition Schedule E) ------------ --------- --------- --------- --------- --------- --------- Unsecured debt (petition Schedule F) ------------ --------- --------- --------- --------- --------- --------- TOTAL PRE PETITION LIABILITIES ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES ------------ --------- --------- --------- --------- --------- --------- SHAREHOLDERS' EQUITY (DEFICIT) PREFERRED STOCK ------------ --------- --------- --------- --------- --------- --------- COMMON STOCK ------------ --------- --------- --------- --------- --------- --------- PAID-IN CAPITAL ------------ --------- --------- --------- --------- --------- --------- RETAINED EARNINGS Through filing date ------------ --------- --------- --------- --------- --------- --------- Post filing date ------------ --------- --------- --------- --------- --------- --------- TOTAL SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- ---------
CASE NAME: RESPONSE ONCOLOGY, INC., et al. SUMMARY OF ACCOUNTS RECEIVABLE FORM OPR-3 ---------------------------------------------------- REV 7/99 CASE NUMBER: 01-24607-DSK MONTH ENDED: February, 2002 ---------------------------------------------------- ---------------
0-30 31-60 61-90 OVER TOTAL DAYS DAYS DAYS 90 DAYS DATE OF FILING: See "Summary of Accounts Receivable" Schedule attached. ----------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ----------
NOTE: Total accounts receivable and total allowance for doubtful accounts shown here must agree with the same items as shown on Form OPR-1. FORM OPR-4 REV 7/99 SCHEDULE OF POST PETITION LIABILITIES CASE NAME: RESPONSE ONCOLOGY, INC. et al. -------------------------------- CASE NUMBER: 01-24607-DSK MONTH ENDED: February, 2002 ------------------------------ ---------------
DATE DATE TOTAL 0-30 31-60 61-90 OVER INCURRED DUE DUE DAYS DAYS DAYS 90 DAYS -------- -------- -------- -------- -------- -------- -------- TAXES PAYABLE Federal Income Tax See "Schedule of Post Petition Liabilities" attached. -------- -------- -------- -------- -------- -------- -------- FICA -------- -------- -------- -------- -------- -------- -------- Unemployment Tax -------- -------- -------- -------- -------- -------- -------- Sales Tax -------- -------- -------- -------- -------- -------- -------- Personal Property Tax -------- -------- -------- -------- -------- -------- -------- TOTAL TAXES PAYABLE -------- -------- -------- -------- -------- -------- -------- POSTPETITION SECURED DEBT -------- -------- -------- -------- -------- -------- -------- POSTPETITION UNSECURED DEBT -------- -------- -------- -------- -------- -------- -------- ACCRUED INTEREST PAYABLE -------- -------- -------- -------- -------- -------- -------- TRADE ACCOUNTS PAYABLE & OTHER: (list separately*) -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- TOTALS -------- -------- -------- -------- -------- -------- --------
*Attach separate page if necessary NOTE: Total postpetition liabilities shown here must agree with the same item as shown on Form OPR-2 of this report. CASE NAME: RESPONSE ONCOLOGY, INC., ET AL. STATEMENT OF INCOME (LOSS) FORM OPR-5 ------------------------------- REV 7/99 CASE NUMBER: 01-24607-DSK MONTH ENDED: February, 2002 ------------------------------- ----------------
FILING MONTH MONTH MONTH MONTH MONTH MONTH TO DATE See "Statement of Income (Loss)" attached. --------- --------- --------- --------- --------- ---------- ---------- NET REVENUE (INCOME) --------- --------- --------- --------- --------- ---------- ---------- COST OF GOODS SOLD Materials --------- --------- --------- --------- --------- ---------- ---------- Labor - Direct --------- --------- --------- --------- --------- ---------- ---------- Manufacturing Overhead --------- --------- --------- --------- --------- ---------- ---------- TOTAL COST OF GOODS SOLD --------- --------- --------- --------- --------- ---------- ---------- GROSS PROFIT --------- --------- --------- --------- --------- ---------- ---------- OPERATING EXPENSES Selling and Marketing --------- --------- --------- --------- --------- ---------- ---------- General and Administrative --------- --------- --------- --------- --------- ---------- ---------- Other:__________________ --------- --------- --------- --------- --------- ---------- ---------- TOTAL OPERATING EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INCOME BEFORE INTEREST, DEPRECIATION, TAXES OR EXTRAORDINARY EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INTEREST EXPENSE --------- --------- --------- --------- --------- ---------- ---------- DEPRECIATION --------- --------- --------- --------- --------- ---------- ---------- INCOME TAX EXPENSE (BENEFIT) --------- --------- --------- --------- --------- ---------- ---------- EXTRAORDINARY INCOME (EXPENSE)* --------- --------- --------- --------- --------- ---------- ---------- NET INCOME (LOSS) --------- --------- --------- --------- --------- ---------- ----------
* Requires Footnote STATEMENT OF SOURCES AND USES OF CASH CASE NAME: RESPONSE ONCOLOGY, INC., et. al ----------------------------------------------------- FORM OPR-6 CASE NUMBER: 01-24607-DSK MONTH ENDED: February, 2002 REV 7/99 --------------------------------------------------- ---------------
MONTH MONTH MONTH MONTH MONTH MONTH --------- --------- --------- --------- --------- --------- See "Statement of Cash Flows" attached. --------- --------- --------- --------- --------- --------- SOURCES OF CASH Income (Loss) From Operations Add: Depreciation, Amortization & Other Non-Cash Items --------- --------- --------- --------- --------- --------- CASH GENERATED FROM OPERATIONS --------- --------- --------- --------- --------- --------- Add: Decrease in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Increase in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL SOURCES OF CASH (A) --------- --------- --------- --------- --------- --------- USES OF CASH Increase in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Decrease in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL USES OF CASH (B) --------- --------- --------- --------- --------- --------- NET SOURCE (USE) OF CASH (A-B=NET) --------- --------- --------- --------- --------- --------- CASH - BEGINNING BALANCE (OPR-1) --------- --------- --------- --------- --------- --------- CASH - ENDING BALANCE (OPR-1) --------- --------- --------- --------- --------- ---------
CERTIFICATE OF SERVICE I hereby certify that a true copy of the foregoing Monthly Operating Report was sent by U.S. Mail properly addressed and with correct postage (or hand delivered) to the persons or offices listed below. Done this day of , 19 . ------ --------------- ---- ---------------------------------- (Signature) ---------------------------------- (Printed name) ---------------------------------- (Street address) ---------------------------------- (City, state, zip) ---------------------------------- (Telephone) ORIGINAL FILED WITH: U.S. Bankruptcy Court - ---------------------------------------- (Address) - ---------------------------------------- (City, state, zip) - ---------------------------------------- (Date) FILE STAMPED COPIES MAILED TO: U.S. Trustee One Memphis Place 200 Jefferson Avenue, Suite 400 Memphis, TN 38103 Members of Creditors Committee (if applicable list names and addresses on separate sheet) List any other interested parties to whom MOR was issued: Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 1. Payroll State the amount of all executive wages paid and taxes withheld and paid.
Taxes ------------------------- Name and Title of Executive Gross Net Amount Due Paid --------------------------------------------------------------------------------------------------------- LaMacchia, Anthony President & CEO 25,750.00 15,626.87 5,900.95 5,900.95 Stark, Pete Chief Financial Officer 14,956.54 9,764.49 3,959.12 3,959.12 -- ------------------------------------------------------- Total Executive Payroll 40,706.54 25,391.36 9,860.07 9,860.07 =======================================================
Schedule 1 Payroll Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK/01-24610L/01-24609L/01-24608B Month of: February 2002 2. Insurance
POLICY TYPE INSURANCE COMPANY COVERAGE AMOUNT - ----------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" Hartford Insurance Company 500,000 - ----------------------------------------------------------------------------------------------------------------------------- Crime Insurance Federal Insurance Company (Chubb) 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime Federal Insurance Company (Chubb) 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability Steadfast Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Automobile Liability Hartford Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Property Lexington Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Property Royal Indemnity Insurance 4,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Property TIG Insurance Company 12,275,770 - ----------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability Hartford Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability Gulf Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Umbrella Liability Chicago Insurance Company 5,000,000/5,000,000 - ----------------------------------------------------------------------------------------------------------------------------- General Liability Chicago Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability Chicago Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) Reliance Insurance Company 10,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability Zurich Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery Continental Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------- Florida Windstorm Florida Windstorm Underwriting Association 850,000 - ----------------------------------------------------------------------------------------------------------------------------- POLICY TYPE POLICY NUMBER EXPIRATION DATE PREMIUM DESCRIPTION - ------------------------------------------------------------------------------------------------------------------------------ Workers Compensation/Employers Liability "All States" 20WBEX6471 8/1/2002 Estimated Ann. Prem. - ------------------------------------------------------------------------------------------------------------------------------ Crime Insurance 81514719A 2/1/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Fiduciary Liability/Crime 81514719A 2/1/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Managed Care Professional Liability APL360208302 2/1/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Automobile Liability 20UENUW8330 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Property 1280081 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Property RHD319956 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Property XPT39245522 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Directors and Officers Liability NDA013978800 6/30/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Excess Directors and Officers Liability GA0689336 3/31/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Umbrella Liability XSC2000073 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ General Liability GLI1038480 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Hospital Professional Liability/General Liability HCC2001017 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Directors and Officers Liability (Tail Coverage) NDA0142699-97 12/1/2003 Prepaid - ------------------------------------------------------------------------------------------------------------------------------ Employment Practices Liability EOC3618914-03 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Boiler & Machinery BM1098379645 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ Florida Windstorm 1237949 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------ DATE COVERAGE POLICY TYPE PREMIUM AMOUNTS PAID THROUGH - ---------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" 44,441 8/1/2002 - ---------------------------------------------------------------------------------------------- Crime Insurance 3,000 2/1/2002 - ---------------------------------------------------------------------------------------------- Fiduciary Liability/Crime 2,075 2/1/2002 - ---------------------------------------------------------------------------------------------- Managed Care Professional Liability 97,375 2/1/2002 - ---------------------------------------------------------------------------------------------- Automobile Liability 3,959 8/1/2002 - ---------------------------------------------------------------------------------------------- Property 106,592 8/1/2002 - ---------------------------------------------------------------------------------------------- Property 15,000 8/1/2002 - ---------------------------------------------------------------------------------------------- Property 25,000 8/1/2002 - ---------------------------------------------------------------------------------------------- Directors and Officers Liability 75,384 6/30/2002 - ---------------------------------------------------------------------------------------------- Excess Directors and Officers Liability 57,812 3/31/2002 - ---------------------------------------------------------------------------------------------- Umbrella Liability 174,269 8/1/2002 - ---------------------------------------------------------------------------------------------- General Liability 3,320 8/1/2002 - ---------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability 142,219 8/1/2002 - ---------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) 90,000 12/1/2003 - ---------------------------------------------------------------------------------------------- Employment Practices Liability 25,895 8/1/2002 - ---------------------------------------------------------------------------------------------- Boiler & Machinery 3,585 8/1/2002 - ---------------------------------------------------------------------------------------------- Florida Windstorm 3,801 8/1/2002 - ----------------------------------------------------------------------------------------------
Schedule 2 Insurance Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 (In Thousands) 3. Bank Accounts
Bank name AmSouth AmSouth AmSouth AmSouth B of A Union Planters Account Name Concentration CDA Payroll Imprest Imprest IMPACT l'box Account # 5323050950 10026193 5323050969 5323050977 0112996871 0182931 ---------------------------------------------------------------------------------- Beginning book balance $ 4,776 $ (484) $ (17) $ -- $ 3 $ -- Plus: Deposits 7,780 -- -- -- -- 1,155 (Attach detailed listing) Less: Disbursements (188) (6,422) (1,115) -- (13) -- (Attach detailed listing) Other: Transfers In (Out) (6,610) 6,288 1,112 -- 15 (1,155) Repo Interest 3 -- -- -- -- Fees (2) -- -- -- -- -- Other 2 -- (30) -- -- ---------------------------------------------------------------------------------- Ending book balance $ 5,761 $ (618) $ (50) $ -- $ 5 $ -- ================================================================================== Bank name PNC 1st TN 1st TN B of A B of A TOTALS Account Name Bus Checking Bus Checking Escrow Operating Payroll Account # 8401093582 101467285 101829712 112996855 112996863 ---------------------------------------------------------------------------------- Beginning book balance $ -- $ -- $ 781 $ -- $ -- $ 5,059 Plus: Deposits -- -- -- -- -- 8,935 (Attach detailed listing) Less: Disbursements -- -- -- -- -- (7,738) (Attach detailed listing) Other: Transfers In (Out) -- 350 -- -- -- Repo Interest -- -- -- -- 3 Fees -- -- -- -- -- (2) Other -- -- -- -- (28) ---------------------------------------------------------------------------------- Ending book balance $ -- $ -- $1,131 $ -- $ -- $ 6,229 ==================================================================================
Schedule 3 Bank Accounts Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 (In Thousands) 3. Bank Accounts - Deposit Listing
W/E 02/01/02 W/E 02/08/02 W/E 02/15/02 W/E 02/22/02 W/E 02/28/02 M/E 02/28/02 ------------ ------------ ------------ ------------ ------------ ------------ ACTUAL ACTUAL ACTUAL ACTUAL ACTUAL ACTUAL ------------ ------------ ------------ ------------ ------------ ------------ CASH RECEIPTS: IMPACT Services 2 34 71 70 19 196 PHARMACY SALES: Admin Fees -- 7 -- -- -- 7 Ft. Wayne -- 339 237 212 191 979 Grand Rapids 14 101 89 138 83 425 Houston -- 235 -- -- -- 235 Memphis -- -- -- -- -- -- Miami -- -- -- -- 1,267 1,267 R&K -- -- -- -- -- -- ----- ----- ----- ----- ----- ----- Total Pharmacy Sales 14 682 326 350 1,541 2,913 ----- ----- ----- ----- ----- ----- PPM REMITTANCES: OHGSF 7 1 2 -- 1 11 Paonessa -- -- 400 400 900 1,700 OHAWB, R&K Division -- -- -- -- -- -- OHAWB, WWW Division -- -- -- -- -- -- Treasure Coast -- 296 465 193 210 1,164 Boca 84 475 551 475 326 2,011 Haraf -- 117 70 269 146 602 ----- ----- ----- ----- ----- ----- Total PPM Remittances 91 889 1,588 1,337 1,583 5,488 ----- ----- ----- ----- ----- ----- Clinical Research Deposits -- -- -- -- -- -- JV Distributions -- -- -- -- -- -- Other -- 166 62 96 14 338 ===== ===== ===== ===== ===== ===== TOTAL CASH RECEIPTS 107 1,771 2,047 1,853 3,157 8,935 ===== ===== ===== ===== ===== =====
Schedule 3 Bank Accounts Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AMSOUTH CDA:
CHECK NUM VENDOR AMOUNT CHECK DATE ----------------------------------------------------------------------------------------------------- 223928 ADVANTA BUSINESS SERVICES CORP (190.80) 2/1/2002 223944 COPYCO INCORPORATED (152.71) 2/1/2002 223947 COPYCO INCORPORATED (183.99) 2/1/2002 223948 COPYCO INCORPORATED (154.15) 2/1/2002 223958 GREAT AMERICA LEASING CORP. (236.73) 2/1/2002 224008 ABBOTT LABORATORIES 9,015.91 2/1/2002 224009 ABEL MEDICAL, INC. 30.00 2/1/2002 224010 ADP INC. 1,512.65 2/1/2002 224011 AMERICAN DENTAL PLAN - FL 306.90 2/1/2002 224012 ARROW INTERNATIONAL, INC. 123.80 2/1/2002 224013 AT&T 163.46 2/1/2002 224014 AT&T 273.07 2/1/2002 224015 AT&T 31.62 2/1/2002 224016 AVENTIS PASTEUR 61.80 2/1/2002 224017 BECKMAN COULTER, INC. 1,029.35 2/1/2002 224018 BELL SOUTH 1,587.28 2/1/2002 224019 BELL SOUTH 1,464.00 2/1/2002 224020 BERGEN BRUNSWIG MEDICAL CORP 16.24 2/1/2002 224021 STERICYCLE, INC. 188.00 2/1/2002 224022 BIO-MED PLUS 14,116.01 2/1/2002 224023 BIO-SPEC, INC. 732.00 2/1/2002 224024 BLUE CROSS OF FLORIDA 3,157.25 2/1/2002 224025 BLUE CROSS OF FLORIDA 14,932.79 2/1/2002 224026 CINGULAR WIRELESS 0.03 2/1/2002 224027 METLIFE SMALL BUSINESS CENTER 951.39 2/1/2002 224028 VERIZON WIRELESS 21.97 2/1/2002 224029 COCA-COLA ENTERPRISES 158.25 2/1/2002 224030 COPYCO INCORPORATED 102.54 2/1/2002 224031 CORD MOVING - MEMPHIS 225.00 2/1/2002 224032 CORPORATE EXPRESS 999.13 2/1/2002 224033 DIAGNOSTIC IMAGING, INC. 56.00 2/1/2002 224034 ELAN DIAGNOSTICS 2,248.75 2/1/2002 224035 EXP PHARMACETUICAL WASTE MGMT 613.27 2/1/2002 224036 EXPRESS COURIER, INC. 105.00 2/1/2002 224037 FEDEX 862.37 2/1/2002 224038 NANCY FOSE 94.27 2/1/2002 224039 FPL 893.60 2/1/2002 224040 GATEWAY GROUP PERSONNEL 570.00 2/1/2002 224041 GENERAL MEDICAL CORPORATION 2,831.01 2/1/2002 224042 BRENDA J. HENDERSHOT 1,320.20 2/1/2002 224043 HEMATRONIX INCORPORATED 44.61 2/1/2002 224044 HORIZON MEDICAL PRODUCTS, INC. 777.43 2/1/2002 224045 INTERNATIONAL COMPUTER 763.20 2/1/2002 224046 IKON OFFICE SOLUTIONS 364.27 2/1/2002 224047 INGENIX 79.95 2/1/2002 224048 KEMPER BUSINESS SYSTEMS 121.98 2/1/2002 224049 HAYLEE MCCREIGHT 16.25 2/1/2002 224050 MCI WORLDCOM 7.77 2/1/2002 224051 MCI WORLDCOM COMMUNICATIONS 0.26 2/1/2002 224052 MEDFORMS 205.26 2/1/2002 224053 OFFICE PRODUCTS & SERVICES, INC. 276.13 2/1/2002 224054 ONCOLOGY SUPPLY COMPANY, INC. 39,339.78 2/1/2002 224055 PALM BEACH NEWSPAPERS, INC. 651.90 2/1/2002 224056 PBCC 1,053.96 2/1/2002 224057 PHELPS DUNBAR LLP 1,054.62 2/1/2002 224058 PROFESSIONAL SERVICES / MGIS CO. 429.60 2/1/2002 224059 PROFESSIONAL OFFICE SERVICES 27.06 2/1/2002 224060 RESERVE ACCOUNT 2,000.00 2/1/2002 224061 SIMS DELTEC, INC. 620.92 2/1/2002 224062 STERICYCLE, INC. 89.00 2/1/2002 224063 STERLING TRUST COMPANY 11,608.66 2/1/2002 224064 SUN SENTINEL 1,106.90 2/1/2002 224065 SOUTHWESTERN BELL - TX 110.30 2/1/2002 224066 TAP PHARMACEUTICALS 6,539.52 2/1/2002 224067 TECHNOLOGY PARTNERS 327.50 2/1/2002 224068 US CELLULAR 104.89 2/1/2002 224069 ONCOLOGY & HEMATOLOGY ASSOC. 52,824.83 2/1/2002 224070 ZENECA PHARMACEUTICALS 1,581.30 2/1/2002 224071 ABBOTT LABORATORIES 1,684.74 2/4/2002 224072 BECKMAN COULTER, INC. 1,921.47 2/4/2002
Schedule 3 Bank Accounts Page 1 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AMSOUTH CDA:
CHECK NUM VENDOR AMOUNT CHECK DATE ----------------------------------------------------------------------------------------------------- 224073 CALTAG LABORATORIES 275.00 2/4/2002 224074 FISHER HEALTHCARE 409.98 2/4/2002 224075 DELL MARKETING L.P. 61.66 2/4/2002 224076 ECONOMY STATIONERS, INC. 672.02 2/4/2002 224077 BAXTER 1,536.00 2/4/2002 224078 EDDIE MARTIN 331.73 2/4/2002 224079 MEDFORMS 263.32 2/4/2002 224080 NET TRANSFORMS, INC. 6,718.50 2/4/2002 224081 OFFICE PRODUCTS & SERVICES, INC. 213.08 2/4/2002 224082 SIMS DELTEC, INC. 387.66 2/4/2002 224083 TAP PHARMACEUTICALS 3,417.66 2/4/2002 224084 BECKMAN COULTER, INC. 2,793.20 2/6/2002 224085 COPYCO INCORPORATED 412.66 2/6/2002 224086 RUSSELL CORNELIUS 161.29 2/5/2002 224087 PAT HENLEY 57.30 2/5/2002 224088 BAXTER 68,750.00 2/5/2002 224089 METRO ALARM OFFICE 35.00 2/5/2002 224090 NEXAIR, LLC 472.44 2/5/2002 224091 POLY-MED, INC. 2,942.00 2/5/2002 224092 PROFESSIONAL CERTIFICATION 1,657.62 2/5/2002 224093 SARSTEDT INCORPORATED 133.56 2/5/2002 224094 ABBOTT LABORATORIES 2717.26 2/7/2002 224095 AT&T 78.59 2/7/2002 224096 AT&T WIRELESS 507.43 2/7/2002 224097 BECKMAN COULTER, INC. 23.75 2/7/2002 224098 BELL SOUTH 11,911.88 2/7/2002 224099 BERGEN BRUNSWIG MEDICAL CORP. 2,073.79 2/7/2002 224100 BERGEN BRUNSWIG MEDICAL CORP. 1,003.60 2/7/2002 224101 CALTAG LABORATORIES 185.00 2/7/2002 224102 CANANWILL, INC. 73,915.15 2/7/2002 224103 CLEANFUELS 360.50 2/7/2002 224104 CORD MOVING - MEMPHIS 371.40 2/7/2002 224105 DELL MARKETING, L.P. 603.64 2/7/2002 224106 ECONOMY STATIONERS, INC. 371.95 2/7/2002 224107 EVERFIT SERVICES 90.95 2/7/2002 224108 FED EX 957.97 2/7/2002 224109 RON FORD OFFICE SUPPLY CO. INC. 608.88 2/7/2002 224110 NANCY FOSE 166.50 2/7/2002 224111 GRAND HYATT WASHINGTON 715.62 2/7/2002 224112 GROSZ & STAMPER CONSTRUCTION 670.00 2/7/2002 224113 ANTHONY M. LAMACCHIA 141.17 2/7/2002 224114 MEDFORMS 158.32 2/7/2002 224115 MEDICAL MANAGER SOUTHEAST, INC. 6,055.00 2/7/2002 224116 MEDICAL TRANSCRIPTION SERVICE 2,770.56 2/7/2002 224117 NATIONAL LINEN SERVICE 226.99 2/7/2002 224118 NU TEL COMMUNICATIONS, INC. 105.00 2/7/2002 224119 OFFICE PRODUCTS & SERVICES INC. 145.65 2/7/2002 224120 PATHOLOGY GROUP / MID SOUTH 5,300.00 2/7/2002 224121 PRN MEDICAL INCORPORATED 294.18 2/7/2002 224122 PROFESSIONAL COMPUTER 285.00 2/7/2002 224123 PROFESSIONAL OFFICE SERVICES 544.04 2/7/2002 224124 PSS - ORLANDO 3,064.37 2/7/2002 224125 PSS - ST. PETERSBURG 479.24 2/7/2002 224126 CALIGOR 2,261.73 2/7/2002 224127 SANDRA ROBERTS 75.92 2/7/2002 224128 STATE OF ILLINOIS 200.00 2/7/2002 224129 STATE OF ILLINOIS 10.00 2/7/2002 224130 SUNCOAST MACHINES 2,798.05 2/7/2002 224131 TACY MEDICAL 1,118.80 2/7/2002 224132 TAP PHARMACEUTICALS 569.61 2/7/2002 224133 STATE OF TN / DEPT OF COMM & INS. 208.00 2/7/2002 224134 UNITED STATES POSTAL SERVICE 300.00 2/7/2002 224135 VALLEY BIOMEDICAL SERVICES 801.05 2/7/2002 224136 XEROGRAPHICS 13,824.70 2/7/2002 224137 ZENECA PHARMACEUTICALS 2,353.48 2/7/2002 223449 PROFESSIONAL COMPUTER (1,504.15) 2/8/2002 223590 PROFESSIONAL COMPUTER (1,455.42) 2/8/2002 224138 BOCA RATON SURGICAL SUPPLY 740.19 2/8/2002 224139 NELLY DAWSON, R.N. 914.91 2/8/2002 224140 GENERAL MEDICAL CORPORATION 750.41 2/8/2002
Schedule 3 Bank Accounts Page 2 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AmSouth CDA:
Check Num Vendor Amount Check Date - ----------------------------------------------------------------------------------------- 224141 ONCOLOGY SUPPLY COMPANY, INC. 65,162.84 2/8/2002 224142 PSS - ORLANDO 4,390.77 2/8/2002 224143 TRIMARC FINANCIAL, INC. 1,455.42 2/8/2002 224144 NANCY ZELL 18.25 2/8/2002 224145 ZENECA PHARMACEUTICALS 170.25 2/8/2002 224146 AGENCY SERVICES 1,460.36 2/8/2002 223927 ADVANTA BUSINESS SERVICES CORP (326.48) 2/11/2002 224147 FIFTH AVENUE LAUNDRY 335.00 2/11/2002 224148 ABBOTT LABORATORIES 2,690.85 2/11/2002 224149 AIRBORNE EXPRESS 346.58 2/11/2002 224150 A&I TRAVEL SERVICE, INC. 230.00 2/11/2002 224151 AKIN, GUMP, STRAUSS, HAUER 40,000.00 2/11/2002 224152 ALL POINTS BIOMEDICAL, INC. 803.46 2/11/2002 224153 ALLSTAR COMMUNICATIONS, INC. 230.25 2/11/2002 224154 AMERI-KLEEN SERVICES, INC. 411.09 2/11/2002 224155 AMPCO SYSTEM PARKING 240.00 2/11/2002 224156 AMTEC MEDICAL INC. 592.49 2/11/2002 224157 ARCH WIRELESS 103.40 2/11/2002 224158 AT&T 25.46 2/11/2002 224159 AT&T 240.78 2/11/2002 224160 AT&T 86.36 2/11/2002 224161 AT&T WIRELESS 1,412.34 2/11/2002 224162 BAY AREA MEDICAL EXCHANGE 484.85 2/11/2002 224163 BAY LINEN, INC. 481.64 2/11/2002 224164 B&B ANSWERING SERVICE 240.00 2/11/2002 224165 BECKMAN COULTER, INC. 5,998.04 2/11/2002 224166 BELLSOUTH 120.19 2/11/2002 224167 BELLSOUTH 2,536.16 2/11/2002 224168 BERGEN BRUNSWIG MEDICAL CORP 4,369.96 2/11/2002 224169 BIO-SPEC, INC. 260.00 2/11/2002 224170 BOCA RATON SURGICAL SUPPLY 2,420.63 2/11/2002 224171 CONFIDENTIAL SHREDDING 75.30 2/11/2002 224172 COOK'S MOBILE SHRESSING SERV 70.69 2/11/2002 224173 COPYCO INCORPORATED 522.77 2/11/2002 224174 CORPORATE EXPRESS 1,860.12 2/11/2002 224175 FISHER HEALTHCARE 287.02 2/11/2002 224176 DIAGNOSTIC IMAGING, INC. 181.73 2/11/2002 224177 DLT HOME OXYGEN 280.00 2/11/2002 224178 DENISE WILSON 5.11 2/11/2002 224179 ECONOMY STATIONERS, INC. 128.36 2/11/2002 224180 ELECTRONIC DATA SUBMISSION 75.60 2/11/2002 224181 EXPRESS COURIER, INC. 677.55 2/11/2002 224182 FEDEX 904.57 2/11/2002 224183 FLORIDA BLOOD SERVICES, INC. 5,821.00 2/11/2002 224184 FLORIDA HEALTHCARE SUPPLY INC. 540.42 2/11/2002 224185 FORBES MAGAZINE 19.99 2/11/2002 224186 FPL 1,606.66 2/11/2002 224187 FT. PIERCE UTILITIES AUTHORITY 185.36 2/11/2002 224188 VERIZON WIRELESS 3,481.82 2/11/2002 224189 HCFA LABORATORY PROGRAM 430.00 2/11/2002 224190 HELLO DIRECT INCORPORATED 29.97 2/11/2002 224191 IKON OFFICE SOLUTIONS 137.94 2/11/2002 224192 IKON OFFICE SOLUTIONS 180.78 2/11/2002 224193 INTERSTATE EXPRESS, INC. 655.50 2/11/2002 224194 KPMG LLP 25,000.00 2/11/2002 224195 LABORATORY CORPORATION OF AMER 210.35 2/11/2002 224196 MARTIN PRINTING 298.77 2/11/2002 224197 MASSEY SERVICES INCORPORATED 83.30 2/11/2002 224198 MCI 5,878.01 2/11/2002 224199 MCI WORLDCOM 254.28 2/11/2002 224200 MEDFORMS 147.80 2/11/2002 224201 MEDICAL MANAGER SOUTHEAST, INC. 413.50 2/11/2002 224202 MEDICAL MANAGER 3,104.03 2/11/2002 224202 MEDICAL MANAGER (3,104.03) 2/11/2002 224203 MICROWAREHOUSE 1,278.18 2/11/2002 224204 NATIONSBANK OF DELAWARE, N.A. 2,727.91 2/11/2002 224205 TRANG NGUYEN 15.33 2/11/2002 224206 NU TEL COMMUNICATIONS, INC. 281.96 2/11/2002 224207 OFFICE DEPOT 531.59 2/11/2002 224208 OFFICE PRODUCTS & SERVICES, INC. 78.86 2/11/2002
SCHEDULE 3 BANK ACCOUNTS Page 3 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AmSouth CDA:
Check Num Vendor Amount Check Date - ----------------------------------------------------------------------------------------- 224209 ONCOLOGY RESOURCE CONSULTANTS 206.25 2/11/2002 224210 DAVID W. O'ROURKE 106.95 2/11/2002 224211 NOTIFY MD DBA PHYSICIAN EXCHANGE 1,313.60 2/11/2002 224212 PIP PRINTING 181.05 2/11/2002 224213 PLAN ADMINISTRATORS, INC. 575.00 2/11/2002 224214 VERIZON WIRELESS 79.62 2/11/2002 224215 PROFESSIONAL COMPUTER 7,797.11 2/11/2002 224216 PROFESSIONAL OFFICE SERVICES 492.07 2/11/2002 224217 PHYSICIAN SALES & SERVICE 4,468.07 2/11/2002 224218 PHYSICIAN SALES & SERVICE 226.31 2/11/2002 224219 RICOH CORPORATION 212.99 2/11/2002 224220 RECORDKEEPERS 1,133.14 2/11/2002 224221 CALIGOR 22,210.63 2/11/2002 224222 SECOND CHANCE LIFE SKILLS, INC. 68.48 2/11/2002 224223 SHARP DATA FORMS INCORPORATED 330.85 2/11/2002 224224 SIMS DELTEC, INC. 2,026.39 2/11/2002 224225 QUEST DIAGNOSTICS 230.00 2/11/2002 224226 SPRINT 365.44 2/11/2002 224227 STERLING TRUST COMPANY 11,918.65 2/11/2002 224228 TACY MEDICAL 256.00 2/11/2002 224229 TAP PHARMACEUTICALS 5,506.23 2/11/2002 224230 TECHNOLOGY PARTNERS 130.00 2/11/2002 224231 VERIZON WIRELESS MESSAGING SERV 17.12 2/11/2002 224232 WEINTRAUB, STOCK, BENNETT 775.50 2/11/2002 224233 WINDWARD COMMUNICATIONS, INC. 419.76 2/11/2002 224234 WESTERN INSTITUTIONAL REVIEW 200.00 2/11/2002 224235 WIRELESS BROADCASTING 63.12 2/11/2002 224236 WORLDCOM TECHNOLOGIES, INC. 255.21 2/11/2002 224237 ZEPHYRHILLS NATURAL SPRING WATER 301.83 2/11/2002 224238 BECKMAN COULTER, INC. 692.50 2/12/2002 224239 LABEL EXPRESS, INC. 120.00 2/12/2002 224240 ONCOLOGY SUPPLY COMPANY, INC. 1,925.46 2/12/2002 224241 VYSIS 827.03 2/12/2002 224242 ARDUS MEDICAL, INC. 1,373.14 2/13/2002 224243 BECKMAN COULTER, INC. 2,485.72 2/13/2002 224244 CALIFORNIA CRYOBANK, INC. 1,610.00 2/13/2002 224245 GENERAL MEDICAL CORPORATION 3,076.56 2/13/2002 224246 BAXTER 232.56 2/13/2002 224247 PHYLLIS KIRBY 384.26 2/13/2002 224248 RICHARD DAVERSA 1,658.23 2/13/2002 224249 CALIGOR 187.27 2/13/2002 224250 ZENECA PHARMACEUTICALS 1,792.10 2/13/2002 224251 ABBOTT LABORATORIES 8,859.66 2/14/2002 224252 ADP INC. 735.32 2/14/2002 224253 AMTEC MEDICAL, INC. 265.54 2/14/2002 224254 BECKMAN COULTER, I NC. 917.45 2/14/2002 224255 BERGEN BRUNSWIG MEDICAL CORP 187.01 2/14/2002 224256 CALIFORNIA CRYOBANK, INC. 4,313.00 2/14/2002 224257 VERIZON WIRELESS 780.85 2/14/2002 224258 COMPUTER RESULTS 2,531.57 2/14/2002 224259 CROWN BANK LEASING 39.62 2/14/2002 224260 FISHER HEALTHCARE 469.46 2/14/2002 224261 ECONOMY STATIONERS, INC. 146.58 2/14/2002 224262 FEDEX 32.94 2/14/2002 224263 FLORIDA BLOOD SERVICES, INC. 572.00 2/14/2002 224264 GENERAL MEDICAL CORPORATION 18,949.80 2/14/2002 224265 HELLO DIRECT INCORPORATED 148.97 2/14/2002 224266 HEMATRONIX INCORPORATED 788.11 2/14/2002 224267 HORIZON MEDICAL PRODUCTS, INC. 1,328.13 2/14/2002 224268 BAXTER 621.76 2/14/2002 224269 MCI WORLDCOM 1,282.98 2/14/2002 224270 MERCEDES MEDICAL, INC. 1,472.18 2/14/2002 224271 ORTHO-CLINICAL DIAGNOSTICS 57.40 2/14/2002 224272 SIMS DELTEC, INC. 487.24 2/14/2002 224273 TAP PHARMACEUTICALS 4,746.75 2/14/2002 224274 ZENECA PHARMACEUTICALS 1,001.49 2/14/2002 224275 AGENCY SERVICES 378.00 2/15/2002 224276 ARMSTRONG ALLEN, PLLC 453.65 2/15/2002 224277 BOCA RATON SURGICAL SUPPLY 7,297.24 2/15/2002 224278 CALIFORNIA CRYOBANK, INC. 271.00 2/15/2002
SCHEDULE 3 BANK ACCOUNTS Page 4 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AmSouth CDA:
Check Num Vendor Amount Check Date - ----------------------------------------------------------------------------------------- 224279 HORSESHOE BENEFITS 295.56 2/15/2002 224280 INTERNAL REVENUE SERVICE 1,525.81 2/15/2002 224281 VETERANS PRESS 932.15 2/15/2002 224282 ONCOLOGY SUPPLY COMPANY, INC. 126,188.18 2/15/2002 224249 CALIGOR (187.27) 2/18/2002 224283 ABEL MEDICAL INC 20.00 2/18/2002 224284 AGENCY FOR HEALTHCARE ADMIN 1,592.00 2/18/2002 224285 AIRCOM, INC. 83.70 2/18/2002 224286 AIRBORNE EXPRESS 172.90 2/18/2002 224287 ALPHA OMEGA BUSINESS SYSTEMS 507.09 2/18/2002 224288 AMTEC MEDICAL INC. 795.77 2/18/2002 224289 AT&T WIRELESS 66.62 2/18/2002 224290 BECKMAN COULTER INC. 7,549.50 2/18/2002 224291 CLEAN NET INC 980.50 2/18/2002 224292 CORPORATE EXPRESS 49.74 2/18/2002 224293 FISHER HEALTHCARE 154.98 2/18/2002 224294 ENS 303.00 2/18/2002 224295 FEDEX 124.74 2/18/2002 224296 FLORIDA BLOOD SERVICES, INC. 812.00 2/18/2002 224297 FPL 1,175.79 2/18/2002 224298 GENERAL MEDICAL CORPORATION 506.67 2/18/2002 224299 GENERAL MEDICAL CORPORATION 724.02 2/18/2002 224300 LANIER HEALTHCARE 104.86 2/18/2002 224301 MEDICAL MANAGER SOUTHEAST, INC. 441.50 2/18/2002 224302 OFFICE DEPOT 1,306.09 2/18/2002 224303 OFFICE PRODUCTS & SERVICES, INC. 1,102.00 2/18/2002 224304 PRN MEDICAL INCORPORATED 215.45 2/18/2002 224305 PROFESSIONAL COMPUTER 570.50 2/18/2002 224306 PROFESSIONAL OFFICE SERVICES 203.22 2/18/2002 224307 RESERVE ACCOUNT 2,000.00 2/18/2002 224308 RHODES LAUCK & ASSOCIATES, INC. 324.42 2/18/2002 224309 CALIGOR 657.12 2/18/2002 224310 SAM'S CLUB/GECF 920.84 2/18/2002 224311 SECURITY BUSINESS RECORDS MGT* 390.72 2/18/2002 224312 SIMS DELTEC, INC. 296.80 2/18/2002 224313 TAP PHARMACEUTICALS 3,607.53 2/18/2002 224314 DENISE A VANDER WEG 98.52 2/18/2002 224315 XEROGRAPHICS 70.69 2/18/2002 224316 CALIGOR 187.27 2/18/2002 223585 OFFICE DEPOT (483.34) 2/19/2002 223891 OFFICE DEPOT (534.61) 2/19/2002 224096 AT&T WIRELESS (507.43) 2/19/2002 224207 OFFICE DEPOT (531.59) 2/19/2002 224317 FRANK M. BUMSTEAD 4,750.00 2/19/2002 224318 P.ANTHONY JACOBS 4,750.00 2/19/2002 224319 LAWRENCE KUGELMAN 4,750.00 2/19/2002 224320 JAMES R. SEWARD 4,750.00 2/19/2002 224321 WILLIAM WEST, M.D. 4,000.00 2/19/2002 224322 BIO-SERVE,INC. 378.00 2/19/2002 224323 DAVID SWEET 325.00 2/19/2002 224324 BRENDA J. HENDERSHOT 1,651.40 2/19/2002 224325 NEXAIR, LLC 608.85 2/19/2002 224326 OFFICE DEPOT 1,549.54 2/19/2002 224327 ONCOLOGY MANAGERS OF FLORIDA 496.00 2/19/2002 224328 PORTLAND MARRIOTT DOWNTOWN 719.20 2/19/2002 224329 PSS-ORLANDO 1,788.18 2/19/2002 224330 SECURITY LINK FROM AMERITECH 79.34 2/19/2002 224332 AGENCY SERVICES 843.25 2/20/2002 224333 BECKMAN COULTER INC. 453.00 2/20/2002 224334 FLOOD, BUMSTEAD, MCCREADY 340.88 2/20/2002 224335 LAWRENCE KUGELMAN 1,083.00 2/20/2002 224335 GENERAL MEDICAL CORPORATION 727.25 2/20/2002 224337 MEADOWS BUSINESS SYSTEMS INC. 513.11 2/20/2002 224338 ONCOLOGY SUPPLY 9,447.95 2/20/2002 224339 GE GROUP LIFE ASSURANCE CO. 1,911.67 2/20/2002 224339 GE GROUP LIFE ASSURANCE CO. (1,911.67) 2/20/2002 224340 PRINTING BY HEARN 2,505.84 2/20/2002 224341 JAMES R. SEWARD 661.13 2/20/2002 224342 SCOTT RINDNER 32,128.75 2/20/2002 222956 THE TRUST COMPANY (1,624.20) 2/21/2002
SCHEULE 3 BANK ACCOUNTS Page 5 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AmSouth CDA:
Check Num Vendor Amount Check Date - ----------------------------------------------------------------------------------------- 224331 AT&T (Check by Direct Debit) 628.68 2/21/2002 224343 ABBOTT LABORATORIES 2,201.72 2/21/2002 224344 ABDICK PRODUCTS CO. 188.41 2/21/2002 224345 ALPHA OMEGA BUSINESS SYSTEMS 432.28 2/21/2002 224346 AMERICAN BUSINESS SECURITY, INC. 180.00 2/21/2002 224347 AMTEC MEDICAL INC. 200.30 2/21/2002 224348 APPALACHIA BUSINESS 99.59 2/21/2002 224349 ARCHIVES MANAGEMENT 946.95 2/21/2002 224350 AT&T 365.09 2/21/2002 224351 AT&T 2,086.90 2/21/2002 224352 AT&T 1,944.91 2/21/2002 224353 AT&T WIRELESS 135.82 2/21/2002 224354 CHRISTINE BAKER 143.00 2/21/2002 224355 BAPTIST & PHYSICIANS PPO 100.00 2/21/2002 224356 BECKMAN COULTER INC. 5,454.45 2/21/2002 224357 VERIZON 5.09 2/21/2002 224358 BELLSOUTH 526.67 2/21/2002 224359 BERGEN BRUNSWIG MEDICAL CORP 803.13 2/21/2002 224360 BROWNING FERRIS INDUSTRIES 148.82 2/21/2002 224361 STERICYCLE/BFI MEDICAL WASTE 3,780.24 2/21/2002 224362 STERICYCLE INC 220.00 2/21/2002 224363 BOCA RATON SURGICAL SUPPLY 3,117.81 2/21/2002 224364 BSMG WORLDWIDE INC 1,284.29 2/21/2002 224365 CHATTANOOGA COCA-COLA 48.21 2/21/2002 224366 CLAUSEN BROTHERS MOVING CO. 554.25 2/21/2002 224367 COMMODORE MEDICAL SERVICES 164.45 2/21/2002 224368 COPYCO INCORPORATED 153.81 2/21/2002 224369 CULLIGAN WATER 9.27 2/21/2002 224370 FISHER HEALTHCARE 1,012.92 2/21/2002 224371 ECONOMY STATIONERS, INC. 382.75 2/21/2002 224372 ELITE PROFESSIONAL SERVICES 120.00 2/21/2002 224373 EXPRESS COURIER, INC. 105.00 2/21/2002 224374 FEDEX 2,238.82 2/21/2002 224375 FLORIDA BLOOD SERVICES, INC. 1,024.00 2/21/2002 224376 FLORIDA HEALTHCARE SUPPLY INC. 10,175.38 2/21/2002 224377 FLORIDA MEDICAL COMPUTERS, INC. 1,009.63 2/21/2002 224378 VERIZON WIRELESS 965.51 2/21/2002 224379 HORIZON MEDICAL PRODUCTS 718.28 2/21/2002 224380 INTERNATIONAL COMPUTER 84.80 2/21/2002 224381 IKON OFFICE SOLUTIONS 180.78 2/21/2002 224382 INTERCALL 349.90 2/21/2002 224383 MALLINCKRODT INC. 1,434.30 2/21/2002 224384 MARTIN MEMORIAL HEALTH SYSTEMS 411.28 2/21/2002 224385 MEMPHIS COMMUNICATIONS CORP. 299.72 2/21/2002 224386 MCI 2,031.77 2/21/2002 224387 MCI WORLDCOM COMMUNICATIONS 487.37 2/21/2002 224388 MEDFORMS 3,653.84 2/21/2002 224389 MEDICAL TRANSCRIPTION SERVICE 3,080.04 2/21/2002 224390 MICRO FILTRATIONS INCORPORATED 220.00 2/21/2002 224391 MEMPHIS LIGHT, GAS AND WATER 214.97 2/21/2002 224392 OFFICE DEPOT 371.44 2/21/2002 224393 OFFICE PRODUCTS & SERVICES, INC. 110.19 2/21/2002 224394 PARAMOUNT/U-LI-KA CLEANERS 53.64 2/21/2002 224395 PBCC 1,150.20 2/21/2002 224396 PIP PRINTING 182.82 2/21/2002 224397 PSS-ST.PETERSBURG 3,485.64 2/21/2002 224398 CALIGOR 9,630.01 2/21/2002 224398 CALIGOR 2,125.83 2/21/2002 224399 SECOND CHANCE LIFE SKILLS, INC. 853.41 2/21/2002 224400 SIMS DELTEC, INC. 383.40 2/21/2002 224401 QUEST DIAGNOSTICS 48.41 2/21/2002 224402 PETE STARK 455.36 2/21/2002 224403 SVI SYSTEMS INCORPORATED 111.83 2/21/2002 224404 TAP PHARMACEUTICALS 1,708.83 2/21/2002 224405 TECHNOLOGY PARTNERS 900.41 2/21/2002 224406 PRIMUS TELECOMMUNICATIONS 81.23 2/21/2002 224407 THE TRUST COMPANY 2,311.15 2/21/2002 224408 VISIBLE COMPUTER SUPPLY 19.50 2/21/2002 224115 MEDICAL MANAGER SOUTHEAST (6,055.00) 2/22/2002 224409 ONCOLOGY SUPPLY 47,847.32 2/22/2002
Schedule 3 Bank Accounts Page 6 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AmSouth CDA:
Check Num Vendor Amount Check Date - ----------------------------------------------------------------------------------------- 224410 ABBOTT LABORATORIES 817.25 2/25/2002 224411 AGA LINDE HEALTHCARE 144.37 2/25/2002 224412 AKIN,GUMP,STRAUSS, HAUER 29,894.02 2/25/2002 224413 SIGNIUS 80.45 2/25/2002 224414 BERGEN BRUNSWIG MEDICAL CORP. 1,995.13 2/25/2002 224415 BERGEN BRUNSWIG MEDICAL CORP. 1,119.89 2/25/2002 224416 BIO-MED PLUS 982.16 2/25/2002 224417 CANANWILL INC. 73,987.15 2/25/2002 224418 COPYCO INCORPORATED 191.70 2/25/2002 224419 CORPORATE EXPRESS 311.74 2/25/2002 224420 FISHER HEALTHCARE 100.56 2/25/2002 224421 CYPRESS REFRESHMENTS, INC. 841.08 2/25/2002 224422 EXPRESS COURIER INC. 105.00 2/25/2002 224423 FEDEX 8.64 2/25/2002 224424 FLORIDA BLOOD SERVICES, INC. 80.00 2/25/2002 224425 GENERAL MEDICAL CORPORATION 304.78 2/25/2002 224426 GENERAL MEDICAL CORPORATION 2,124.45 2/25/2002 224427 GREENBERG TRAURIG HOFFMAN 7,856.21 2/25/2002 224428 HARRIS,SHELTON,DUNLAP,COBB 7,509.23 2/25/2002 224429 HORIZON MEDICAL PRODUCTS, INC. 979.20 2/25/2002 224430 MCI 4,972.69 2/25/2002 224431 MCI WORLDCOM 0.75 2/25/2002 224432 MEDIFAX EDI 5.00 2/25/2002 224433 MEDICAL MANAGER 1,190.00 2/25/2002 224434 METROPOLITAN TRUSTEE 1,175.59 2/25/2002 224435 MICRO FILTRATIONS INCORPORATED 1,141.81 2/25/2002 224436 NU TEL COMMUNICATIONS, INC. 140.00 2/25/2002 224437 PHILIPS MEDICAL SYSTEMS 1,599.92 2/25/2002 224438 PROFESSIONAL OFFICE SERVICES 27.06 2/25/2002 224439 PSS-ORLANDO 14,278.56 2/25/2002 224440 PYRAMID COURIERS, INC. 20.00 2/25/2002 224441 NICOLE ROLESON 1,168.47 2/25/2002 224442 SECURITY SYSTEMS OF MEMPHIS 65.00 2/25/2002 224443 SEO ENTERPRISES INCORPORATED 110.00 2/25/2002 224444 SHARP DATA FORMS INCORPORATED 107.17 2/25/2002 224445 SHELBY COUNTY TRUSTEE 17,540.50 2/25/2002 224446 STATEWIDE MEDICAL SERVICES 171.00 2/25/2002 224447 STUART NEWS 527.53 2/25/2002 224448 SUN TRUST BANK 2,330.86 2/25/2002 224449 TAP PHARMACEUTICALS 6,392.68 2/25/2002 224450 TENNESSEE ASSOC ELECTRIC, INC. 210.00 2/25/2002 224451 XEROGRAPHICS 246.26 2/25/2002 224452 ZENECA PHARMACEUTICALS 841.24 2/25/2002 224453 9330 PW CONDOMINIUM LLC 2,228.33 2/26/2002 224454 ADVANTA BUSINESS SERVICES 326.48 2/26/2002 224455 ADVANTA BUSINESS SERVICES 190.80 2/26/2002 224456 BAPTIST MEDICAL ARTS BLDG. 7,562.14 2/26/2002 224457 BOCA RATON COMMUNITY HOSPITAL 8,501.26 2/26/2002 224458 BOCA RATON SURGICAL SUPPLY 4,629.15 2/26/2002 224459 CAPROCK INVESTMENTS, LLC. 49,988.30 2/26/2002 224460 CDR MEDICAL ASSOCIATES, LTD. 16,817.44 2/26/2002 224461 CDR MEDICAL ASSOCIATES, LTD. 6,157.26 2/26/2002 224462 COPYCO INCORPORATED 172.31 2/26/2002 224463 COPYCO INCORPORATED 151.83 2/26/2002 224464 COPYCO INCORPORATED 154.87 2/26/2002 224465 CROWN BANK LEASING 295.13 2/26/2002 224466 C.S.C. CONDOMINIUM ASSOCIATION 229.55 2/26/2002 224467 DIAGNOSTIC CLINIC OF HOUSTON 1,024.25 2/26/2002 224468 EQUIPMENT LEASING COMPANY 461.97 2/26/2002 224469 ERVIN LEASING 120.97 2/26/2002 224470 FORT WAYNE MEDICAL ONCOLOGY 520.50 2/26/2002 224471 GE MEDICAL SYSTEMS 8,781.00 2/26/2002 224471 GE MEDICAL SYSTEMS 7,083.84 2/26/2002 224472 HEM-ONC PROPERTIES 24,747.97 2/26/2002 224473 GENE CHRUSCIEL 29.95 2/26/2002 224474 JEFFERSON MEDICAL COMMONS 604.83 2/26/2002 224475 LEASECARD 1,696.00 2/26/2002 224476 LHT KNOXVILLE LLC 5,274.48 2/26/2002 224477 MARTIN MEMORIAL MEDICAL CENTER 3,965.28 2/26/2002 224478 COLUMBIA MEDICAL GROUP 450.00 2/26/2002
SCHEDULE 3 BANK ACCOUNTS Page 7 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AMSOUTH CDA:
CHECK NUM VENDOR AMOUNT CHECK DATE ----------------------------------------------------------------------------------------------------- 224479 MITA FINANCIAL SERVICES 580.07 2/26/2002 224480 COVENANT HEALTH PROPERTIES 8,880.26 2/26/2002 224481 GE GROUP LIFE ASSURANCE CO. 1,706.98 2/26/2002 224482 PMPSSJ, LTD. 7,758.11 2/26/2002 224483 RCFA HEALTHCARE MGMT. SVCS. LLC 85.00 2/26/2002 224484 RICHARD DAVERSA 2,133.71 2/26/2002 224485 WEST MICHIGAN HEMA/ONCO,P.C. 1,035.62 2/26/2002 224486 PROFESSIONAL OFFICE BUILDING 18,524.93 2/26/2002 224487 STERLING TRUST COMPANY 11,678.19 2/26/2002 224488 TOSHIBA AMERICA INFO SYS INC. 170.12 2/26/2002 224489 THE TRUST COMPANY 1,373.18 2/26/2002 224490 VANGUARD FINANCIAL SERV. CORP 150.06 2/26/2002 224491 VANGUARD FINANCIAL SERV. CORP 150.06 2/26/2002 224492 WESTON MANAGEMENT COMPANY 1,750.00 2/26/2002 224493 CALIFORNIA CRYOBANK, INC. 408.00 2/27/2002 224494 GENERAL MEDICAL CORPORATION 528.00 2/27/2002 224495 ONCOLOGY SUPPLY 50,787.70 2/27/2002 224496 ABBOTT LABORATORIES 4,352.89 2/28/2002 224497 ADP INC 2,304.18 2/28/2002 224498 AGENCY SERVICES 315.00 2/28/2002 224499 BAY AREA MEDICAL EXCHANGE 454.46 2/28/2002 224500 BECKMAN COULTER, INC. 2,099.42 2/28/2002 224501 BECTON-DICINSON 5,789.47 2/28/2002 224502 BERGEN BRUNSWIG MEDICAL CORP. 2,120.93 2/28/2002 224503 BIO-RAD LABORATORIES 908.91 2/28/2002 224504 BIO-SPEC, INC. 804.50 2/28/2002 224505 BOCA RATON SURGICAL SUPPLY 1,525.63 2/28/2002 224506 CORPORATE EXPRESS 32.91 2/28/2002 224507 FISHER HEALTHCARE 205.71 2/28/2002 224508 FPL 105.58 2/28/2002 224509 GENERAL MEDICAL CORPORATION 7,734.96 2/28/2002 224510 HUMANA HEALTH INSURANCE OF FL. 12,916.65 2/28/2002 224511 INTERSTATE EXPRESS INC. 588.50 2/28/2002 224512 NEXAIR,LLC 850.20 2/28/2002 224513 OFFICE DEPOT 49.41 2/28/2002 224514 OFFICE PRODUCTS & SERVICES INC. 401.73 2/28/2002 224515 ONCOLOGY SUPPLY 32.31 2/28/2002 224516 PROFESSIONAL OFFICE SERVICES 60.58 2/28/2002 224517 CALIGOR 1,474.40 2/28/2002 224518 SEO ENTERPRISES INCORPORATED 6.60 2/28/2002 224519 SIGMA INTERNATIONAL 259.00 2/28/2002 224520 TAP PHARMACEUTICALS 4,746.75 2/28/2002 224521 UNICOMP CORP OF AMERICA 770.00 2/28/2002 224522 UNITED HEALTHCARE 32,670.69 2/28/2002 224523 UNUM LIFE INSURANCE 538.50 2/28/2002 224524 UNITED STATES POSTAL SERVICE 900.00 2/28/2002 224525 VERIZON WIRELESS MESSAGING SRV 17.12 2/28/2002 224526 XEROGRAPHICS 208.79 2/28/2002 Debit NSS 1,555,555.87 Various Debit OTNJV 3,230,624.32 Various Debit Professional Computer Systems / Support 3,980.86 02/07/02 ------------ Total Disb M/E 2/28/02 - CDA 6,421,157.98 ------------
Schedule 3 Bank Accounts Page 8 of 8 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 3. Bank Accounts - Disbursement Listing AMSOUTH CONCENTRATION ACCOUNT:
TRANSACTION PAYEE/DESCRIPTION AMOUNT DATE - ----------------------------------------------------------------------------------------------------------- Debit Interest Payment - Senior Debt 131,038.71 Debit Fidelity / 401(k) Plan 57,310.84 ---------- Total Disb M/E 2/28/02 - Concentration 188,349.55 ----------
BANK OF AMERICA IMPREST ACCOUNT:
TRANSACTION PAYEE/DESCRIPTION AMOUNT DATE - ---------------------------------------------------------------------------------------- Checks/Debit Various 13,242.29 Various ---------
AMSOUTH PAYROLL ACCOUNT:
PPE COMPANY/DESCRIPTION GROSS TAXES TOTAL P/R - ---------------------------------------------------------------------------------------------------------------- VE4/ROI $ 178,707.26 $ 73,107.22 $ 251,814.48 VE8/PAO 60,209.49 35,470.96 95,680.45 VFA/TRC 31,425.08 16,816.09 48,241.17 VFC/BOC 61,549.78 41,193.13 102,742.91 VFD/HRF 23,558.73 11,452.43 35,011.16 -------------------------------------------------------- PPE 02/01/02 $ 355,450.34 $ 178,039.83 $ 533,490.17 ======================================================== VE4/ROI $ 165,228.69 $ 67,678.75 $ 232,907.44 VE8/PAO 55,614.08 31,113.48 86,727.56 VFA/TRC 30,872.81 16,606.82 47,479.63 VFC/BOC 100,189.81 79,491.65 179,681.46 VFD/HRF 23,441.89 11,379.77 34,821.66 -------------------------------------------------------- PPE 02/15/02 $ 375,347.28 $ 206,270.47 $ 581,617.75 ======================================================== TOTAL $ 730,797.62 $ 384,310.30 $1,115,107.92 ======================================================== TOTAL DISBURSEMENTS - M/E 2/28/02 7,737,857.74 ==============
Schedule 3 Bank Accounts Page 1 of 1 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 4. Postpetition Payments Payments to:
CK COURT ORDER PAYEE AMT DATE NUM DATE - ------------------------------------------------------------------------------------------------------------------------------------ Professionals (attorneys, accountants, etc.) Akin, Gump, Strauss,Hauer & Feld, LLP $ 40,000 2/11/2002 224151 April 3, 2001 Akin, Gump, Strauss,Hauer & Feld, LLP 29,894 2/25/2002 224412 April 3, 2001 Greenberg, Traurig, Hoffman 7,856 2/25/2002 224427 June 30, 2001 Harris, Shelton, Dunlap, Cobb & Ryder 7,509 2/25/2002 224428 April 3, 2001 KPMG LLP 25,000 2/11/2002 224194 June 13, 2001 Scott Rindner 32,129 2/20/2002 224342 July 30, 2001 Prepetition debts: No payments on prepetition debts made during February, 2002 -- n/a n/a 4/3/2001 (Supplemented 5/18/01)
Schedule 4 Postpetition Payments Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 (In Thousands) Comparative Balance Sheets
Filing Date March 29, April 30, May 31, 2001 2001 2001 --------- --------- --------- ASSETS CURRENT ASSETS Cash and cash equivalents $ 4,153 $ 10,126 $ 7,045 Accounts receivable 13,906 13,844 13,293 Less: Allowance for doubtful accounts (3,591) (3,555) (3,565) Supplies and pharmaceuticals 3,035 3,513 3,741 Prepaid expenses and other current assets 3,616 3,560 3,248 Due from affiliated physician groups 13,338 13,406 13,011 Deferred income taxes 1,168 1,168 1,168 --------- --------- --------- TOTAL CURRENT ASSETS 35,625 42,062 37,939 PROPERTY, PLANT & EQUIPMENT, at cost 13,913 13,760 13,588 Less: Accumulated depreciation and amortization (11,942) (11,845) (11,758) --------- --------- --------- NET PROPERTY, PLANT & EQUIPMENT 1,971 1,915 1,830 OTHER ASSETS Deferred charges 476 476 476 Less: Accumulated amortization, deferred charges (398) (424) (450) Management service agreements 51,917 51,917 51,917 Less: Accumulated amortization, management service agreements (8,220) (8,398) (8,577) Other assets (1) (1,450) (1,437) (1,437) Intercompany receivable (payable) 17,250 16,862 16,998 --------- --------- --------- 59,575 58,996 58,928 --------- --------- --------- TOTAL ASSETS $ 97,171 $ 102,973 $ 98,697 ========= ========= ========= LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities and accruals -- $ 7,442 $ 3,369 Pre-petition liabilities: Secured debt $ 29,199 29,199 29,199 Priority debt 21 21 21 Unsecured debt: Accounts payable and accrued expenses 16,285 16,285 16,285 Subordinated notes payable 756 756 756 Capital lease obligations 512 489 467 Other GAAP accruals not included in schedules 2,684 1,367 1,367 Deferred income taxes 3,525 3,525 3,525 --------- --------- --------- TOTAL LIABILITIES 52,982 59,084 54,989 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end 17 17 17 Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (2) 123 123 123 Paid-in capital 102,011 102,011 102,011 Accumulated deficit: Through filing date (57,962) (57,962) (57,962) Post filing date -- (300) (481) --------- --------- --------- 44,189 43,889 43,708 --------- --------- --------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 97,171 $ 102,973 $ 98,697 ========= ========= ========= -- -- -- June 30, July 31, August 31, 2001 2001 2001 --------- --------- ---------- ASSETS CURRENT ASSETS Cash and cash equivalents $ 7,659 $ 6,442 $ 6,218 Accounts receivable 12,821 13,105 13,329 Less: Allowance for doubtful accounts (3,800) (3,813) (3,751) Supplies and pharmaceuticals 3,691 3,773 3,904 Prepaid expenses and other current assets 3,179 3,060 3,263 Due from affiliated physician groups 12,344 11,779 11,460 Deferred income taxes 1,168 1,168 1,168 --------- --------- --------- TOTAL CURRENT ASSETS 37,061 35,514 35,591 PROPERTY, PLANT & EQUIPMENT, at cost 12,696 12,688 12,703 Less: Accumulated depreciation and amortization (11,028) (11,113) (11,206) --------- --------- --------- NET PROPERTY, PLANT & EQUIPMENT 1,668 1,575 1,497 OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements 51,917 51,917 51,917 Less: Accumulated amortization, management service agreements (8,755) (8,933) (9,112) Other assets (1) (1,437) (1,437) (1,437) Intercompany receivable (payable) 16,913 16,922 16,743 --------- --------- --------- 58,638 58,469 58,111 --------- --------- --------- TOTAL ASSETS $ 97,368 $ 95,558 $ 95,199 ========= ========= ========= LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities and accruals $ 2,446 $ 956 $ 943 Pre-petition liabilities: Secured debt 29,199 29,199 29,199 Priority debt 21 21 21 Unsecured debt: Accounts payable and accrued expenses 16,285 16,285 16,285 Subordinated notes payable 756 756 756 Capital lease obligations 444 421 405 Other GAAP accruals not included in schedules 1,367 1,367 1,367 Deferred income taxes 3,525 3,525 3,525 --------- --------- --------- TOTAL LIABILITIES 54,043 52,530 52,501 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end 17 17 17 Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (2) 123 123 123 Paid-in capital 102,011 102,011 102,011 Accumulated deficit: Through filing date (57,962) (57,962) (57,962) Post filing date (863) (1,161) (1,491) --------- --------- --------- 43,325 43,028 42,698 --------- --------- --------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 97,368 $ 95,558 $ 95,199 ========= ========= ========= -- -- -- September 30, October 31, November 30, 2001 2001 2001 ------------- ----------- ------------ ASSETS CURRENT ASSETS Cash and cash equivalents $ 6,400 $ 6,476 $ 6,425 Accounts receivable 12,150 10,156 8,663 Less: Allowance for doubtful accounts (3,874) (3,860) (3,353) Supplies and pharmaceuticals 3,967 3,593 3,599 Prepaid expenses and other current assets 3,282 3,020 2,934 Due from affiliated physician groups 11,646 11,414 11,759 Deferred income taxes -- -- -- --------- --------- --------- TOTAL CURRENT ASSETS 33,571 30,799 30,027 PROPERTY, PLANT & EQUIPMENT, at cost 12,615 12,198 12,203 Less: Accumulated depreciation and amortization (11,218) (10,885) (10,975) --------- --------- --------- NET PROPERTY, PLANT & EQUIPMENT 1,397 1,313 1,228 OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements 51,917 51,917 51,917 Less: Accumulated amortization, management service agreements (9,290) (9,468) (9,647) Other assets (1) (1,436) (1,588) (1,588) Intercompany receivable (payable) 16,701 16,796 16,807 --------- --------- --------- 57,892 57,657 57,489 --------- --------- --------- TOTAL ASSETS $ 92,860 $ 89,769 $ 88,744 ========= ========= ========= LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities and accruals $ 1,626 $ 1,608 $ 1,261 Pre-petition liabilities: Secured debt 29,199 26,554 26,407 Priority debt 21 21 21 Unsecured debt: Accounts payable and accrued expenses 16,285 16,285 16,285 Subordinated notes payable 756 756 756 Capital lease obligations 390 374 359 Other GAAP accruals not included in schedules 1,413 1,413 1,413 Deferred income taxes 688 537 345 --------- --------- --------- TOTAL LIABILITIES 50,378 47,548 46,847 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end 17 17 17 Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (2) 123 123 123 Paid-in capital 102,011 102,011 102,011 Accumulated deficit: Through filing date (57,962) (57,962) (57,962) Post filing date (1,707) (1,968) (2,292) --------- --------- --------- 42,482 42,221 41,897 --------- --------- --------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 92,860 $ 89,769 $ 88,744 ========= ========= ========= -- -- -- December 31, January 31, February, 2001 2002 2002 ------------ ----------- --------- ASSETS CURRENT ASSETS Cash and cash equivalents $ 6,328 $ 5,059 $ 6,229 Accounts receivable 7,563 8,166 7,114 Less: Allowance for doubtful accounts (2,342) (1,980) (1,847) Supplies and pharmaceuticals 3,598 3,129 2,921 Prepaid expenses and other current assets 2,648 2,562 2,661 Due from affiliated physician groups 10,262 10,903 10,019 Deferred income taxes -- -- -- --------- --------- --------- TOTAL CURRENT ASSETS 28,057 27,839 27,097 PROPERTY, PLANT & EQUIPMENT, at cost 12,087 12,132 12,121 Less: Accumulated depreciation and amortization (10,897) (10,956) (11,025) --------- --------- --------- NET PROPERTY, PLANT & EQUIPMENT 1,190 1,176 1,096 OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements 48,641 48,641 48,641 Less: Accumulated amortization, management service agreements (9,217) (9,385) (9,552) Other assets (1) (1,987) (1,987) (1,987) Intercompany receivable (payable) 16,891 15,845 16,008 --------- --------- --------- 54,328 53,114 53,110 --------- --------- --------- TOTAL ASSETS $ 83,575 $ 82,129 $ 81,303 ========= ========= ========= LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities and accruals $ 1,946 $ 2,168 $ 1,810 Pre-petition liabilities: Secured debt 26,407 25,336 25,336 Priority debt 21 21 21 Unsecured debt: Accounts payable and accrued expenses 16,285 16,285 16,285 Subordinated notes payable 306 306 306 Capital lease obligations 169 156 143 Other GAAP accruals not included in schedules 1,400 1,400 1,332 Deferred income taxes 0 0 0 --------- --------- --------- TOTAL LIABILITIES 46,534 45,672 45,233 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end 17 17 17 Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (2) 123 123 123 Paid-in capital 102,011 102,011 102,011 Accumulated deficit: Through filing date (57,962) (57,962) (57,962) Post filing date (7,148) (7,732) (8,119) --------- --------- --------- 37,041 36,457 36,070 --------- --------- --------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 83,575 $ 82,129 $ 81,303 ========= ========= ========= -- -- --
Note/ The Balance Sheet, Statement of Income (Loss) and Statement of Cash Flows represents Response Oncology, Inc. which filed a voluntary petition under Chapter 11. The LLCs majority-owned by ROI are not consolidated in the attached schedules. The carrying value of various assets of ROI as of December 31, 2001, could be subject to material adjustments pending finalization of various sales transactions in 2002 and the completion of the Company's audit by KPMG, LLP. (1) Negative balance due to credit balances in certain investment in LLC accounts. These credit balances are due to distributions in excess of the original investment. When reporting on a consolidated basis, these accounts would be eliminated in consolidation. (2) Outstanding shares at December 31, 2001, January 31, 2002 and February 28, 2002 were 12,279,555. Comparative Balance Sheet Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 (In Thousands) Summary of Accounts Receivable
DESCRIPTION CURRENT 31-50 81-90 >90 DAYS BALANCE - ------------------------------------------------------------------------------------------------------------------- April 2001: IMPACT Accounts Receivable 6,696 604 913 4,833 13,046 Atif Hussein, M.D. 96 40 34 166 336 Reference Lab 103 85 53 220 461 ------------------------------------------------------------------------------- Total 6,895 729 1,000 5,219 13,844 =============================================================================== Allowance for Doubtful Accounts (3,558) --------- Net A/R 10,289 ========= May 2001: IMPACT Accounts Receivable 4,438 3,101 286 4,729 12,554 Atif Hussein, M.D. 124 41 21 143 329 Reference Lab 101 75 48 186 410 ------------------------------------------------------------------------------- Total 4,663 3,217 355 5,058 13,293 =============================================================================== Allowance for Doubtful Accounts (3,565) --------- Net A/R 9,728 ========= June 2001: IMPACT Accounts Receivable 6,778 350 169 4,784 12,071 Atif Hussein, M.D. 120 70 18 97 305 Reference Lab 117 74 41 213 445 ------------------------------------------------------------------------------- Total 7,015 494 218 5,094 12,821 =============================================================================== Allowance for Doubtful Accounts (3,600) --------- Net A/R 9,021 ========= July 2001: IMPACT Accounts Receivable 3,996 3,560 166 4,561 12,283 Atif Hussein, M.D. 182 84 49 88 403 Reference Lab 130 72 34 183 419 ------------------------------------------------------------------------------- Total 4,308 3,716 249 4,832 13,105 =============================================================================== Allowance for Doubtful Accounts (3,813) --------- Net A/R 9,292 ========= August 2001: IMPACT Accounts Receivable 4,154 2,445 1,610 4,341 12,550 Atif Hussein, M.D. 136 113 32 102 383 Reference Lab 82 87 21 206 396 ------------------------------------------------------------------------------- Total 4,372 2,645 1,663 4,649 13,329 =============================================================================== Allowance for Doubtful Accounts (3,751) --------- Net A/R 9,578 ========= September 2001: IMPACT Accounts Receivable 3,712 3,279 78 4,328 11,397
Summary of Accounts Receivable Page 1 of 2 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 (In Thousands) Summary of Accounts Receivable
Summary of Accounts Receivable Atif Hussein, M.D. 129 47 21 83 280 Reference Lab 115 70 66 222 473 ------------------------------------------------------------------------------- Total 3,956 3,396 165 4,633 12,150 =============================================================================== Allowance for Doubtful Accounts (3,874) --------- Net A/R 8,276 ========= October 2001: IMPACT Accounts Receivable 2,748 2,527 49 4,151 9,475 Atif Hussein, M.D. -- -- 55 124 179 Reference Lab 88 105 48 261 502 ------------------------------------------------------------------------------- Total 2,836 2,632 152 4,536 10,156 =============================================================================== Allowance for Doubtful Accounts (3,880) --------- Net A/R 6,296 ========= November 2001: IMPACT Accounts Receivable 4,260 170 61 3,595 8,086 Atif Hussein, M.D. -- -- -- 133 133 Reference Lab 60 45 62 277 444 ------------------------------------------------------------------------------- Total 4,320 215 123 4,005 8,663 =============================================================================== Allowance for Doubtful Accounts (3,353) --------- Net A/R 5,310 ========= December 2001: IMPACT Accounts Receivable 2,463 1,904 9 2,625 7,001 Atif Hussein, M.D. -- -- -- 95 95 Reference Lab 72 45 27 323 467 ------------------------------------------------------------------------------- Total 2,535 1,949 36 3,043 7,563 =============================================================================== Allowance for Doubtful Accounts (2,342) --------- Net A/R 5,221 ========= January 2002: IMPACT Accounts Receivable 3,431 1,876 1 2,351 7,659 Atif Hussein, M.D. -- -- -- 81 81 Reference Lab 78 52 24 272 426 ------------------------------------------------------------------------------- Total 3,509 1,929 25 2,704 8,166 =============================================================================== Allowance for Doubtful Accounts (1,980) --------- Net A/R 6,186 ========= February 2002: IMPACT Accounts Receivable 4,406 345 -- 1,890 6,641 Atif Hussein, M.D. -- -- -- 57 57 Reference Lab 86 50 27 253 416 ------------------------------------------------------------------------------- Total 4,492 395 27 2,200 7,114 =============================================================================== Allowance for Doubtful Accounts (1,847) --------- Net A/R 5,267 =========
SUMMARY OF ACCOUNTS RECEIVABLE Page 2 of 2 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 Postpetition Liabilities - OPR4 TAXES PAYABLE Federal Income Tax (Receivable)/Payable $ -- FICA -- Unemployment Tax -- Sales Tax -- Personal Property Tax -- TOTAL TAXES PAYABLE -- POSTPETITION SECURED DEBT -- POSTPETITION UNSECURED DEBT -- ACCRUED INTEREST PAYABLE (7,768) TRADE ACCOUNTS PAYABLE & OTHER: TRADE ACCOUNTS PAYABLE (Paid per terms as due): A&I TRAVEL SERVICE, INC. 30 ABBOTT LABORATORIES 14,526 ABDICK PRODUCTS CO. 194 ABEL MEDICAL, INC. 20 ACCENT INSURANCE RECOVERY SOLUTIONS 1,947 ADP, INC. 827 AETNA US HEALTHCARE 25 AIRBORNE EXPRESS 299 AIRGAS 102 AKIN, GUMP, STRAUSS, HAUER & FELD 123,633 ALLEGIANCE HEALTHCARE CORP. 2,874 ALL POINTS BIOMEDICAL, INC. 161 ALLSTAR COMMUNICATIONS 75 ALLTEK CABLING TECHNOLOGIES 331 ALPHA OMEGA BUSINESS SYSTEMS 1,231 AMERISOURCE (8,303) AMERI-KLEEN SERVICES, INC. 411 AMSOUTH BANK 25,000 AON 23,389 APPALACHIA BUSINESS SYSTEMS 170 APPLIED IMAGING SYSTEMS 16 ARCHIVES MANAGEMENT 785 ARCH WIRELESS 149 AT&T (665) AT&T WIRELESS 97 BAXTER 27,068 BAY LINEN, INC. 342 BECKMAN COULTER, INC. 11,930 BECTON-DICKINSON 1,020 BELL SOUTH 8,068 BERGEN BRUNSWIG MEDICAL CORP. 3,353
Schedule of Postpetition Liabilities (OPR4) Page 1 of 4 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 Postpetition Liabilities - OPR4 BIO-MED PLUS 1,920 BIO-SPEC, INC. 677 BLOSSER ELECTRIC, INC. 159 BOCA RATON SURGICAL SUPPLY 618 BRENDA J. HENDERSHOT 1,114 CALIGOR 1,475 CALIGOR SOUTH (79) CALTAG LABORATORIES 505 CANCER TREATMENT CONSULTANTS 360 CAROL PHELPS 1,458 CENTRAL PARKING SYSTEM 140 CLEAN AIR TECHNOLOGIES 173 COCA-COLA ENTERPRISES 173 COLLEGE OF AMERICAN PATHOLOGISTS (610) COMMODORE MEDICAL SERVICES 179 COPYCO INCORPORATED 212 CORPORATE EXPRESS 3,419 COLORADO STATE BOARD OF PHARMACY 160 CYPRESS REFRESHMENTS, INC. 766 DADE BEHRING 755 DANKA 491 DENISE VANDER WEG 67 DIAGNOSTIC IMAGING 112 ECONOMY STATIONERS, INC. 3,503 EXPRESS COURIER, INC. 548 FACTS AND COMPARISONS 373 FEDEX 2,713 FIFTH AVENUE LAUNDRY 370 FISHER HEALTHCARE 1,739 FLORIDA BLOOD SERVICES, INC. 9,554 FLORIDA COCA-COLA BOTTLING CO. (107) FORT WAYNE MEDICAL ONCOLOGY 628 FPL 1,593 FT. PIERCE UTILITIES AUTHORITY 189 GATEWAY GROUP PERSONNEL 198 GE CAPITAL CORPORATION 181 GENERAL MEDICAL (148) GROSZ & STAMPER CONSTRUCTION 3,186 HORIZON MEDICAL PRODUCTS, INC. 758 INTERNATIONAL COMPUTER 763 INTERSTATE EXPRESS, INC. 477 KPMG LLP 25,000 KRISANN HOWELL 210 LANIER HEALTHCARE 46 MALLINCKRODT, INC. 3,183 MARTIN PRINTING 672 MASSEY SERVICES INCORPORATED 59 MCI 4,973 MCI WORLDCOM 1,271 MEDFORMS 82 MEDICAL DISTRIBUTION, INC. (592) MEDICAL MANAGER 595 MEDICAL MANAGER SOUTHEAST, INC. 475 MEDTRONIC USA, INC. 140 MEMPHIS COMMUNICATIONS CORP. 92
Schedule of Postpetition Liabilities (OPR4) Page 2 of 4 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 Postpetition Liabilities - OPR4 MERCY HOSPITAL 62,014 NATIONSBANK OF DELAWARE, N.A. 3,861 NATIONWIDE MEDICAL WASTE 2,595 NEXAIR, LLC 464 NEW HORIZONS 225 NOTIFY MD DBA PHYSICIAN EXCHANGE 1,536 NSS 6,009 OFFICE DEPOT 160 OFFICE PRODUCTS & SERVICES, INC. 2,529 ONCOLOGY SUPPLY COMPANY, INC. 79,024 OTN (102,057) PAT HENLEY 38 PATHOLOGY GROUP OF MID-SOUTH 13,286 PBCC 329 PDR/RED BOOK 157 PHARMACIA & UPJOHN (2,685) PINNACLE PRODUCTS & SERVICES 21 PITNEY BOWES 164 PITNEYWORKS (51) PORTLAND WELDING SUPPLY 391 PRIMUS TELECOMMUNICATIONS 91 PROFESSIONAL COMPUTER 4,162 PROFESSIONAL OFFICE SERVICES 27 PSS - DEERFIELD (1,353) PSS - KNOXVILLE 1,754 PSS - ORLANDO 252 PSS - ST. PETERSBURG 248 QUORUM REVIEW 1,400 RECORDKEEPERS 636 ROSS KERNS, M.D. 85 RUSSELL CORNELIUS 526 SECOND CHANCE LIFE SKILLS 303 SIGMA INTERNATIONAL 227 SIMS DELTEC, INC. 3,078 SPRINT 366 SPRINT PCS 100 STERICYCLE, INC./BFI MEDICAL WASTE 316 STERICYCLE, INC. 53 SOUTHWESTERN BELL - DALLAS (68) SOUTHWESTERN BELL - TX 470 SUN SENTINEL 641 TACY MEDICAL 3,937 TAMPA BAY MEDICAL PRINTING 458 TAP PHARMACEUTICALS 113,534 TECHNOLOGY PARTNERS 796 TRINA NEILSON 81 US CELLULAR (287) US TRUSTEE 7,167 VERIZON WIRELESS 560 VERIZON WIRELESS 3,200 VWR SCIENTIFIC PRODUCTS CORP. (309) W.B. SAUNDERS COMPANY 91 WHOLESALE AUDIO/VIDEO 164 WESTERN INSTITUTIONAL REVIEW 1,800 WORLDCOM TECHNOLOGIES 97
Schedule of Postpetition Liabilities (OPR4) Page 3 of 4 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 Postpetition Liabilities - OPR4 WYETH - AYERST LABORATORIES (1,625) ZENECA PHARMACEUTICALS (896) ZEPHYRHILLS NATURAL SPRING WATER 333 ----------- $ 526,498 =========== OTHER A/P & ACCRUED LIABILITIES: Physician Purchased Services $ (112,650) MSO/Medical Director Fees (18,585) BOD Fees/Shareholder Services 37,845 Accrued Payroll 335,403 Accrued Bonuses/Severance 17,302 Accrued Legal & Accounting 863,987 Reserve for Termination of MSA 213,865 Other Accrued Expenses (45,866) ----------- TOTAL OTHER LIABILITIES $ 1,291,301 =========== ----------- TOTAL POSTPETITION LIABILITIES $ 1,810,031 -----------
Schedule of Postpetition Liabilities (OPR4) Page 4 of 4 Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 Statement of Income (Loss) (In Thousands)
April May June July 2001 2001 2001 2001 -------- -------- ------- ------- NET REVENUE $ 9,370 $ 10,366 $ 9,160 $ 9,204 COSTS AND EXPENSES Salaries and benefits 1,141 1,213 1,100 1,058 Pharmaceuticals and supplies 7,449 7,894 7,288 7,385 Other operating costs 267 410 231 290 General and administrative 488 621 607 467 Provision for doubtful accounts 22 19 254 9 Loss on impairment of physician practices -- -- -- -- -------- -------- ------- ------- 9,367 10,157 9,480 9,209 -------- -------- ------- ------- EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA) 3 209 (320) (5) Interest expense 206 189 176 163 Depreciation and amortization 234 282 273 275 -------- -------- ------- ------- LOSS BEFORE INCOME TAXES (437) (262) (770) (443) Income tax benefit (137) (80) (388) (145) -------- -------- ------- ------- NET LOSS $ (300) $ (181) $ (382) $ (298) ======== ======== ======= ======= August September October November December 2001 2001 2001 2001 2001 ------- ------- ------- -------- -------- NET REVENUE $ 9,487 $ 8,653 $ 8,721 $ 8,080 $ 7,150 COSTS AND EXPENSES Salaries and benefits 1,142 962 1,009 1,062 1,184 Pharmaceuticals and supplies 7,580 6,906 6,847 6,163 5,794 Other operating costs 298 201 227 172 195 General and administrative 520 427 654 778 900 Provision for doubtful accounts 9 80 7 14 (239) Loss on impairment of physician practices -- -- -- -- 4,137 ------- ------- ------- -------- -------- 9,549 8,576 8,744 8,189 11,971 ------- ------- ------- -------- -------- EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA) (62) 77 (23) (109) (4,821) Interest expense 162 159 142 124 112 Depreciation and amortization 271 270 270 268 268 ------- ------- ------- -------- -------- LOSS BEFORE INCOME TAXES (495) (352) (435) (501) (5,201) Income tax benefit (165) (136) (174) (177) (345) ------- ------- ------- -------- -------- NET LOSS $ (330) $ (216) $ (261) $ (324) $ (4,856) ======= ======= ======= ======== ======== January February Filing 2002 2002 To Date ------- --------- --------- NET REVENUE $ 9,053 $ 6,926 $ 96,170 COSTS AND EXPENSES Salaries and benefits 1,000 822 11,692 Pharmaceuticals and supplies 7,457 5,293 76,057 Other operating costs 198 162 2,651 General and administrative 621 679 6,762 Provision for doubtful accounts (5) 0 170 Loss on impairment of physician practices -- -- 4,137 ------- --------- --------- 9,271 6,956 101,470 ------- --------- --------- EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA) (218) (30) (5,299) Interest expense 113 105 1,651 Depreciation and amortization 253 252 2,916 ------- --------- --------- LOSS BEFORE INCOME TAXES (584) (387) (9,866) Income tax benefit -- -- (1,747) ------- --------- --------- NET LOSS $ (584) $ (387) $ (8,119) ======= ========= =========
NOTE/ The results of operations for the month and filing-to-date through December 31, 2001 could be subject to material adjustments pending finalization of various sales transactions in 2002 and the completion of the Company's audit by KPMG, LLP, specifically related to losses on impairment of physician practices. Statement of Income (Loss) Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK Month of: February 2002 (In Thousands) Statement of Cash Flows
Month Ended Month Ended 4/30/2001 5/31/2001 ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (300) (181) Adjustments to reconcile net earnings from operations: Depreciation and amortization 234 282 Deferred income taxes -- -- Provision for losses on accounts receivable 22 19 (Gain)/loss on sale of property and equipment (9) (6) Impairment of MSAs and associated assets -- -- Changes in assets and liabilities: Accounts receivable 4 542 Supplies, prepaid expenses, and other current assets (422) 90 Deferred charges, other assets and intercompany receivable (payable) 401 (136) Net advances to affiliated physician groups (68) 396 Accounts payable and accrued expenses 6,125 (4,059) -------- -------- NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 5,987 (3,053) INVESTING ACTIVITIES Proceeds from sale of property and equipment 14 6 Purchase of equipment (5) (12) -------- -------- NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 9 (6) FINANCING ACTIVITIES Principal payments on notes payable -- -- Principal payments on capital lease obligations (23) (22) Distribution from joint venture -- -- -------- -------- NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (23) (22) INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 5,973 (3,081) Cash and cash equivalents at beginning of period 4,153 10,126 -------- -------- CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 10,126 $ 7,045 ======== ======== Month Ended Month Ended 6/30/2001 7/31/2001 ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (382) (298) Adjustments to reconcile net earnings from operations: Depreciation and amortization 273 275 Deferred income taxes -- -- Provision for losses on accounts receivable 254 9 (Gain)/loss on sale of property and equipment (1) 1 Impairment of MSAs and associated assets -- -- Changes in assets and liabilities: Accounts receivable 453 (280) Supplies, prepaid expenses, and other current assets 112 37 Deferred charges, other assets and intercompany receivable (payable) 111 (9) Net advances to affiliated physician groups 667 565 Accounts payable and accrued expenses (891) (1,489) ------- ------- NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 596 (1,189) INVESTING ACTIVITIES Proceeds from sale of property and equipment 41 3 Purchase of equipment -- (8) ------- ------- NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 41 (5) FINANCING ACTIVITIES Principal payments on notes payable -- -- Principal payments on capital lease obligations (23) (23) Distribution from joint venture -- -- ------- ------- NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (23) (23) INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 614 (1,217) Cash and cash equivalents at beginning of period 7,045 7,659 ------- ------- CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 7,659 $ 6,442 ======= ======= Month Ended Month Ended 8/31/2001 9/30/2001 ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (330) (216) Adjustments to reconcile net earnings from operations: Depreciation and amortization 271 270 Deferred income taxes -- (1,669) Provision for losses on accounts receivable 9 80 (Gain)/loss on sale of property and equipment 4 (4) Impairment of MSAs and associated assets -- -- Changes in assets and liabilities: Accounts receivable (295) 1,222 Supplies, prepaid expenses, and other current assets (332) (82) Deferred charges, other assets and intercompany receivable (payable) 179 42 Net advances to affiliated physician groups 319 (311) Accounts payable and accrued expenses (13) 854 ------- ------- NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (188) 186 INVESTING ACTIVITIES Proceeds from sale of property and equipment 4 27 Purchase of equipment (24) (16) ------- ------- NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (20) 11 FINANCING ACTIVITIES Principal payments on notes payable -- -- Principal payments on capital lease obligations (16) (15) Distribution from joint venture -- -- ------- ------- NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (16) (15) INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (224) 182 Cash and cash equivalents at beginning of period 6,442 6,218 ------- ------- CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 6,218 $ 6,400 ======= ======= Month Ended Month Ended 10/31/2001 11/30/2001 ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (261) (324) Adjustments to reconcile net earnings from operations: Depreciation and amortization 270 268 Deferred income taxes (151) (192) Provision for losses on accounts receivable 7 14 (Gain)/loss on sale of property and equipment (11) 0 Impairment of MSAs and associated assets -- -- Changes in assets and liabilities: Accounts receivable 1,973 972 Supplies, prepaid expenses, and other current assets 636 80 Deferred charges, other assets and intercompany receivable (payable) (95) (11) Net advances to affiliated physician groups 232 (345) Accounts payable and accrued expenses (18) (347) ------- ------- NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 2,582 115 INVESTING ACTIVITIES Proceeds from sale of property and equipment 12 0 Purchase of equipment (9) (4) ------- ------- NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 3 (4) FINANCING ACTIVITIES Principal payments on notes payable (2,645) (147) Principal payments on capital lease obligations (16) (15) Distribution from joint venture 152 0 ------- ------- NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (2,509) (162) INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 76 (51) Cash and cash equivalents at beginning of period 6,400 6,476 ------- ------- CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 6,476 $ 6,425 ======= ======= Month Ended Month Ended 12/31/2001 1/31/2002 ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (4,856) (584) Adjustments to reconcile net earnings from operations: Depreciation and amortization 268 253 Deferred income taxes (345) -- Provision for losses on accounts receivable (239) (5) (Gain)/loss on sale of property and equipment 15 1 Impairment of MSAs and associated assets 4,137 -- Changes in assets and liabilities: Accounts receivable 382 (960) Supplies, prepaid expenses, and other current assets 110 556 Deferred charges, other assets and intercompany receivable (payable) (94) 1,046 Net advances to affiliated physician groups 398 (641) Accounts payable and accrued expenses 149 222 ------- ------- NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (75) (112) INVESTING ACTIVITIES Proceeds from sale of property and equipment 0 5 Purchase of equipment (8) (78) ------- ------- NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (8) (73) FINANCING ACTIVITIES Principal payments on notes payable -- (1,071) Principal payments on capital lease obligations (14) (13) Distribution from joint venture 0 0 ------- ------- NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (14) (1,084) INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (97) (1,269) Cash and cash equivalents at beginning of period 6,425 6,328 ------- ------- CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 6,328 $ 5,059 ======= ======= Month Ended Filing 2/28/2002 To Date ----------- -------- OPERATING ACTIVITIES Net earnings (loss) (387) (8,119) Adjustments to reconcile net earnings from operations: Depreciation and amortization 252 2,916 Deferred income taxes -- (2,357) Provision for losses on accounts receivable 0 170 (Gain)/loss on sale of property and equipment 2 (8) Impairment of MSAs and associated assets -- 4,137 Changes in assets and liabilities: Accounts receivable 919 4,932 Supplies, prepaid expenses, and other current assets 109 894 Deferred charges, other assets and intercompany receivable (payable) (163) 1,271 Net advances to affiliated physician groups 884 2,096 Accounts payable and accrued expenses (426) 107 ------- ------- NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 1,190 6,039 INVESTING ACTIVITIES Proceeds from sale of property and equipment 18 130 Purchase of equipment (25) (189) ------- ------- NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (7) (59) FINANCING ACTIVITIES Principal payments on notes payable -- (3,863) Principal payments on capital lease obligations (13) (193) Distribution from joint venture 0 152 ------- ------- NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (13) (3,904) INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 1,170 2,076 Cash and cash equivalents at beginning of period 5,059 4,153 ------- ------- CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 6,229 $ 6,229 ======= =======
Statement of Cash Flows MONTHLY OPERATING REPORT COVER SHEET, CHECKLIST, & CERTIFICATE OF SERVICE UNITED STATES BANKRUPTCY COURT WESTERN DISTRICT OF TENNESSEE Case No.: 01-24610L In re: Response Oncology of ------------- ---------------------------------- Tamarac, Inc. Judge: David S. Kennedy ---------------------------------- ---------------- Debtor(s) Chapter 11 MONTHLY OPERATING REPORT FOR MONTH ENDING February 28, 2002 COME(S) NOW, Response Oncology of Tamarac, Inc. Debtor-In-Possession, and hereby submits its Monthly Operating Report for the period commencing February 1 and ending February 28 as shown by the report and exhibits consisting of 16 pages and containing the following as indicated: X Monthly Reporting Questionnaire (Attachment 1) --- X Comparative Balance Sheets (Forms OPR-1 & OPR-2) --- X Summary of Accounts Receivable (Form OPR-3) --- X Schedule of Postpetition Liabilities (Form OPR-4) --- X Statement of Income (Loss) (Form OPR-5) --- X Statement of Sources and Uses of Cash (Form OPR-6) --- X Certificate of Service --- ACCOUNTING METHOD USED: Cash --- X Accrual --- I declare under penalty of perjury that this Report and all attachments are true and correct to the best of my knowledge and belief. I also hereby certify that the original Monthly Operating Report was filed with the Bankruptcy Court Clerk and a file stamped copy delivered to the U.S. Trustee. Date: May 8, 2002 ----------- DEBTOR-IN-POSSESSION By: /s/ Peter A. Stark ---------------------------------------- (Signature) Name & Title: Peter A. Stark, CFO ----------------------------- (Print or Type) Address: 1805 Moriah Woods Blvd. ---------------------------------- Memphis, TN 38117 -------------------------------------------- Telephone Number: (901) 761-7000 --------------------------- ATTACHMENT 1 (PAGE 1 of 4) CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: RESPONSE ONCOLOGY OF TAMARAC, INC. --------------------------------------------- CASE NUMBER: 01-24610L ------------------------------------------- MONTH OF: February 2002 ---------------------------------------------- 1. PAYROLL State the amount of all executive wages paid and taxes withheld and paid.
WAGES PAID TAXES ---------------------- ---------------------------- NAME AND TITLE OF EXECUTIVE GROSS NET AMOUNT DUE PAID - --------------------------- ------- ------- ------------ ---------- none - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- Total Executive Payroll: ----------------------------------------------------------------------
2. INSURANCE Is workers' compensation and other insurance in effect? YES Are payments current? YES If any policy has lapsed, been replaced or renewed, so state in the schedule below. Attach a copy of the new policy's binder or cover page.
DATE COVERAGE EXPIRATION PREMIUM COVERAGE TYPE NAME OF CARRIER AMOUNT POLICY # DATE AMOUNT PD. THRU - ---- --------------- -------- -------- ---------- ------- -------- Casualty See Schedule 2 attached. ------------------------------------------------------------------------------------------------------------ Workers' comp. ------------------------------------------------------------------------------------------------------- General liab. ------------------------------------------------------------------------------------------------------- Vehicle -------------------------------------------------------------------------------------------------------------- Other (specify): ----------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------- REV 7/99
ATTACHMENT 1 (PAGE 2 of 4) CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: Response Oncology of Tamarac, Inc. ---------------------------------------------------- CASE NUMBER: 01-24610L -------------------------------------------------- MONTH OF: February, 2002 ----------------------------------------------------- 3. Bank Accounts
Account Type --------------------------------------------------------------------- Operating Tax Payroll Other Total --------- --------- --------- --------- --------- Bank name None None None None --------- --------- --------- --------- Account # --------- --------- --------- --------- Beginning book balance --------- --------- --------- --------- --------- Plus: Deposits (Attach detailed listing) --------- --------- --------- --------- --------- Less: Disbursements (Attach detailed listing) --------- --------- --------- --------- --------- Other: Transfers In (Out) ----0---- --------- --------- --------- --------- --------- Ending book balance --------- --------- --------- --------- ---------
4. Postpetition Payments. List any postpetition payments to professionals and payments on prepetition debts in the schedule below (attach a separate sheet if necessary).
Payments To/On Amount Date Check # Court Order Date - -------------- --------- --------- --------- ---------------- Professionals (attorneys, accountants, etc.): None - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- Prepetition debts: None - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ----------------
REV 7/99 ATTACHMENT 1 (PAGE 3 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF RECEIPTS CASE NAME: Response Oncology of Tamarac, Inc. -------------------------------------------- CASE NUMBER: 01-24610L ------------------------------------------ MONTH OF: February, 2002 -------------------------------------------- BANK NAME: ACCOUNT #: ------------------------- ------------------------- Detail of Receipts:
Date Received From Explanation Amount - --------- -------------------------- -------------------------- -------------------------- None - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- Total Receipts None *Must agree to "Deposits" line of Item 3 on Attachment 1 (Page 2). -------------------------- REV 7/99 (attach additional sheets if necessary)
ATTACHMENT 1 (PAGE 4 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF DISBURSEMENTS CASE NAME: Response Oncology of Tamarac, Inc. ---------------------------------------------- CASE NUMBER: 01-246101 -------------------------------------------- MONTH OF: February 2002 ----------------------------------------------- BANK NAME: None ACCOUNT #: -------------------------- -------------------------------- Detail of Disbursements:
Date Check # Paid To/In Payment Of Amount - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ----------
Total Disbursements None *Must agree to "Disbursements" line of Item --------------- 3 on Attachment 1 (Page 2). REV 7/99 (attach additional sheets if necessary) CASE NAME: Response Oncology COMPARATIVE BALANCE SHEETS FORM OPR-1 --------------------- REV 7/99 of Tamarac, Inc. --------------------- CASE NUMBER: 01-24610L MONTH ENDED: February, 2002 ------------------- --------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------ ----- ----- ----- ----- ----- ----- ASSETS CURRENT ASSETS Cash See "Comparative Balance Sheets" attached. ----- ----- ----- ----- ----- ----- ----- Other negotiable instruments (i.e. CD's, Treasury bills, etc.) ----- ----- ----- ----- ----- ----- ----- Accounts receivable, net (See OPR-3) ----- ----- ----- ----- ----- ----- ----- Less allowance for doubtful accounts ----- ----- ----- ----- ----- ----- ----- Inventory, at lower of cost of market ----- ----- ----- ----- ----- ----- ----- Prepaid expenses and deposits ----- ----- ----- ----- ----- ----- ----- Investments ----- ----- ----- ----- ----- ----- ----- Other ------------------------------------ ----- ----- ----- ----- ----- ----- ----- TOTAL CURRENT ASSETS ----- ----- ----- ----- ----- ----- ----- PROPERTY, PLANT & EQUIPMENT, AT COST ----- ----- ----- ----- ----- ----- ----- Less accumulated depreciation ----- ----- ----- ----- ----- ----- ----- NET PROPERTY, PLANT & EQUIPMENT ----- ----- ----- ----- ----- ----- ----- OTHER ASSETS ----- ----- ----- ----- ----- ----- ----- - ------------------------------------------- ----- ----- ----- ----- ----- ----- ----- TOTAL ASSETS ----- ----- ----- ----- ----- ----- -----
* Itemize on separate page if value of "Other Assets" exceeds 10% of "Total Assets". CASE NAME: Response Oncology of Tamarac, Inc. COMPARATIVE BALANCE SHEETS ----------------------------------- FORM OPR-2 CASE NUMBER: 01-2461OL MONTH ENDED: February, 2002 REV 7/99 --------------------------------- -----------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------------ --------- --------- --------- --------- --------- --------- LIABILITIES POST PETITION LIABILITIES (See OPR-4) -0- See "Comparative Balance Sheets" attached. --------- --------- --------- --------- --------- --------- PRE PETITION LIABILITIES Secured debt (petition Schedule D) ------------ --------- --------- --------- --------- --------- --------- Priority debt (petition Schedule E) ------------ --------- --------- --------- --------- --------- --------- Unsecured debt (petition Schedule F) ------------ --------- --------- --------- --------- --------- --------- TOTAL PRE PETITION LIABILITIES ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES ------------ --------- --------- --------- --------- --------- --------- SHAREHOLDERS' EQUITY (DEFICIT) PREFERRED STOCK ------------ --------- --------- --------- --------- --------- --------- COMMON STOCK ------------ --------- --------- --------- --------- --------- --------- PAID-IN CAPITAL ------------ --------- --------- --------- --------- --------- --------- RETAINED EARNINGS Through filing date ------------ --------- --------- --------- --------- --------- --------- Post filing date ------------ --------- --------- --------- --------- --------- --------- TOTAL SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- ---------
CASE NAME: Response Oncology of Tamarac, Inc. SUMMARY OF ACCOUNTS RECEIVABLE FORM OPR-3 ---------------------------------------------------- REV 7/99 CASE NUMBER: 01-24610L MONTH ENDED: February, 2002 ---------------------------------------------------- ---------------
0-30 31-60 61-90 OVER TOTAL DAYS DAYS DAYS 90 DAYS DATE OF FILING: None ----------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ----------
NOTE: Total accounts receivable and total allowance for doubtful accounts shown here must agree with the same items as shown on Form OPR-1. FORM OPR-4 REV 7/99 SCHEDULE OF POST PETITION LIABILITIES CASE NAME: Response Oncology of Tamarac, Inc. ------------------------------------ CASE NUMBER: 01-24610L MONTH ENDED: February, 2002 ------------------------------ ---------------
DATE DATE TOTAL 0-30 31-60 61-90 OVER INCURRED DUE DUE DAYS DAYS DAYS 90 DAYS -------- -------- -------- -------- -------- -------- -------- TAXES PAYABLE Federal Income Tax None -------- -------- -------- -------- -------- -------- -------- FICA -------- -------- -------- -------- -------- -------- -------- Unemployment Tax -------- -------- -------- -------- -------- -------- -------- Sales Tax -------- -------- -------- -------- -------- -------- -------- Personal Property Tax -------- -------- -------- -------- -------- -------- -------- TOTAL TAXES PAYABLE -------- -------- -------- -------- -------- -------- -------- POSTPETITION SECURED DEBT -------- -------- -------- -------- -------- -------- -------- POSTPETITION UNSECURED DEBT -------- -------- -------- -------- -------- -------- -------- ACCRUED INTEREST PAYABLE -------- -------- -------- -------- -------- -------- -------- TRADE ACCOUNTS PAYABLE & OTHER: (list separately*) -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- TOTALS None -------- -------- -------- -------- -------- -------- --------
*Attach separate page if necessary NOTE: Total postpetition liabilities shown here must agree with the same item as shown on Form OPR-2 of this report. CASE NAME: Response Oncology of Tamarac, Inc. STATEMENT OF INCOME (LOSS) FORM OPR-5 ------------------------------- REV 7/99 CASE NUMBER: 01-2461OL MONTH ENDED: February, 2002 ------------------------------- ----------------
FILING MONTH MONTH MONTH MONTH MONTH MONTH TO DATE See "Statement of Income (Loss)" attached. --------- --------- --------- --------- --------- ---------- ---------- NET REVENUE (INCOME) --------- --------- --------- --------- --------- ---------- ---------- COST OF GOODS SOLD Materials --------- --------- --------- --------- --------- ---------- ---------- Labor - Direct --------- --------- --------- --------- --------- ---------- ---------- Manufacturing Overhead --------- --------- --------- --------- --------- ---------- ---------- TOTAL COST OF GOODS SOLD --------- --------- --------- --------- --------- ---------- ---------- GROSS PROFIT --------- --------- --------- --------- --------- ---------- ---------- OPERATING EXPENSES Selling and Marketing --------- --------- --------- --------- --------- ---------- ---------- General and Administrative --------- --------- --------- --------- --------- ---------- ---------- Other:__________________ --------- --------- --------- --------- --------- ---------- ---------- TOTAL OPERATING EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INCOME BEFORE INTEREST, DEPRECIATION, TAXES OR EXTRAORDINARY EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INTEREST EXPENSE --------- --------- --------- --------- --------- ---------- ---------- DEPRECIATION --------- --------- --------- --------- --------- ---------- ---------- INCOME TAX EXPENSE (BENEFIT) --------- --------- --------- --------- --------- ---------- ---------- EXTRAORDINARY INCOME (EXPENSE)* --------- --------- --------- --------- --------- ---------- ---------- NET INCOME (LOSS) --------- --------- --------- --------- --------- ---------- ----------
* Requires Footnote STATEMENT OF SOURCES AND USES OF CASH CASE NAME: Response Oncology of Tamarac, Inc. ----------------------------------------------------- FORM OPR-6 CASE NUMBER: 01-24610L MONTH ENDED: February, 2002 REV 7/99 --------------------------------------------------- ---------------
MONTH MONTH MONTH MONTH MONTH MONTH --------- --------- --------- --------- --------- --------- See "Statement of Cash Flows" attached. --------- --------- --------- --------- --------- --------- SOURCES OF CASH Income (Loss) From Operations Add: Depreciation, Amortization & Other Non-Cash Items --------- --------- --------- --------- --------- --------- CASH GENERATED FROM OPERATIONS --------- --------- --------- --------- --------- --------- Add: Decrease in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Increase in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL SOURCES OF CASH (A) --------- --------- --------- --------- --------- --------- USES OF CASH Increase in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Decrease in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL USES OF CASH (B) --------- --------- --------- --------- --------- --------- NET SOURCE (USE) OF CASH (A-B=NET) --------- --------- --------- --------- --------- --------- CASH - BEGINNING BALANCE (OPR-1) --------- --------- --------- --------- --------- --------- CASH - ENDING BALANCE (OPR-1) --------- --------- --------- --------- --------- ---------
CERTIFICATE OF SERVICE I hereby certify that a true copy of the foregoing Monthly Operating Report was sent by U.S. Mail properly addressed and with correct postage (or hand delivered) to the persons or offices listed below. Done this day of , 19 . ------ --------------- ---- ---------------------------------- (Signature) ---------------------------------- (Printed name) ---------------------------------- (Street address) ---------------------------------- (City, state, zip) ---------------------------------- (Telephone) ORIGINAL FILED WITH: U.S. Bankruptcy Court - ---------------------------------------- (Address) - ---------------------------------------- (City, state, zip) - ---------------------------------------- (Date) FILE STAMPED COPIES MAILED TO: U.S. Trustee One Memphis Place 200 Jefferson Avenue, Suite 400 Memphis, TN 38103 Members of Creditors Committee (if applicable list names and addresses on separate sheet) List any other interested parties to whom MOR was issued: Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK/01-24610L/01-24609L/01-24608B Month of: February 2002 2. Insurance
- ----------------------------------------------------------------------------------------------------------------------------------- Policy Type Insurance Company Coverage Amount - ----------------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" Hartford Insurance Company 500,000 - ----------------------------------------------------------------------------------------------------------------------------------- Crime Insurance Federal Insurance Company (Chubb) 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime Federal Insurance Company (Chubb) 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability Steadfast Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Automobile Liability Hartford Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Property Lexington Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Property Royal Indemnity Insurance 4,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Property TIG Insurance Company 12,275,770 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability Hartford Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability Gulf Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Umbrella Liability Chicago Insurance Company 5,000,000/5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- General Liability Chicago Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability Chicago Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) Reliance Insurance Company 10,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability Zurich Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery Continental Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Florida Windstorm Florida Windstorm Underwriting Association 850,000 - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- Policy Type Policy Number Expiration Date Premium Description - ------------------------------------------------------------------------------------------------------------------------------------ Workers Compensation/Employers Liability "All States" 20WBEX6471 8/1/2002 Estimated Ann. Prem. - ------------------------------------------------------------------------------------------------------------------------------------ Crime Insurance 81514719A 2/1/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Fiduciary Liability/Crime 81514719A 2/1/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Managed Care Professional Liability APL360208302 2/1/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Automobile Liability 20UENUW8330 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Property 1280081 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Property RHD319956 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Property XPT39245522 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Directors and Officers Liability NDA013978800 6/30/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Excess Directors and Officers Liability GA0689336 3/31/2002 Semi Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Umbrella Liability XSC2000073 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ General Liability GLI1038480 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Hospital Professional Liability/General Liability HCC2001017 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Directors and Officers Liability (Tail Coverage) NDA0142699-97 12/1/2003 Prepaid - ------------------------------------------------------------------------------------------------------------------------------------ Employment Practices Liability EOC3618914-03 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Boiler & Machinery BM1098379645 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ Florida Windstorm 1237949 8/1/2002 Annual Premium - ------------------------------------------------------------------------------------------------------------------------------------ - ---------------------------------------------------------------------------------------------------------------------- Policy Type Premium Amounts Date Coverage Paid Through - ---------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" 44,441 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Crime Insurance 3,000 2/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime 2,075 2/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability 97,375 2/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Automobile Liability 3,959 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Property 106,592 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Property 15,000 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Property 25,000 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability 75,384 6/30/2002 - ---------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability 57,812 3/31/2002 - ---------------------------------------------------------------------------------------------------------------------- Umbrella Liability 174,269 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- General Liability 3,320 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability 142,219 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) 90,000 12/1/2003 - ---------------------------------------------------------------------------------------------------------------------- Employment Practices Liability 25,895 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Boiler & Machinery 3,585 8/1/2002 - ---------------------------------------------------------------------------------------------------------------------- Florida Windstorm 3,801 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------
Schedule 2 Insurance Case Name: RESPONSE ONCOLOGY OF TAMARAC, INC. Case Number: 01-24610L Month of: February 2002 (In Thousands) Comparative Balance Sheets
Filing Date March 29, April 30, May 31, 2001 2001 2001 ----------- ---------- ---------- ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals 154 182 241 Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups 1,327 907 1,017 Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL CURRENT ASSETS 1,481 1,089 1,258 PROPERTY, PLANT & EQUIPMENT, at cost 786 786 786 Less: Accumulated depreciation and amortization (397) (411) (425) ---------- ---------- ---------- NET PROPERTY, PLANT & EQUIPMENT 389 375 361 OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 18,482 18,870 18,697 ---------- ---------- ---------- 18,482 18,870 18,697 ---------- ---------- ---------- TOTAL ASSETS $ 20,352 $ 20,334 $ 20,316 ========== ========== ========== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 29,199 29,199 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL LIABILITIES 29,199 29,199 29,199 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (8,847) (8,847) (8,847) Post filing date -- (18) (36) ---------- ---------- ---------- (8,847) (8,865) (8,883) ---------- ---------- ---------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 20,352 $ 20,334 $ 20,316 ========== ========== ========== 0 0 0 June 30, July 31, August 31, 2001 2001 2001 ---------- ---------- ---------- ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals 200 188 196 Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups 981 984 778 Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL CURRENT ASSETS 1,181 1,172 974 PROPERTY, PLANT & EQUIPMENT, at cost 783 782 782 Less: Accumulated depreciation and amortization (439) (453) (465) ---------- ---------- ---------- NET PROPERTY, PLANT & EQUIPMENT 344 329 317 OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 18,782 18,777 18,953 ---------- ---------- ---------- 18,782 18,777 18,953 ---------- ---------- ---------- TOTAL ASSETS $ 20,307 $ 20,278 $ 20,244 ========== ========== ========== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 29,199 29,199 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL LIABILITIES 29,199 29,199 29,199 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (8,847) (8,847) (8,847) Post filing date (45) (74) (108) ---------- ---------- ---------- (8,892) (8,921) (8,955) ---------- ---------- ---------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 20,307 $ 20,278 $ 20,244 ========== ========== ========== -- -- -- September 30, October 31, November 30, 2001 2001 2001 ------------- ----------- ------------ ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals 211 221 248 Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups 826 917 863 Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL CURRENT ASSETS 1,037 1,138 1,111 PROPERTY, PLANT & EQUIPMENT, at cost 784 784 784 Less: Accumulated depreciation and amortization (479) (493) (502) ---------- ---------- ---------- NET PROPERTY, PLANT & EQUIPMENT 305 291 282 OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 18,864 16,125 15,992 ---------- ---------- ---------- 18,864 16,125 15,992 ---------- ---------- ---------- TOTAL ASSETS $ 20,206 $ 17,554 $ 17,385 ========== ========== ========== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 26,554 26,407 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL LIABILITIES 29,199 26,554 26,407 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (8,847) (8,847) (8,847) Post filing date (146) (153) (175) ---------- ---------- ---------- (8,993) (9,000) (9,022) ---------- ---------- ---------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 20,206 $ 17,554 $ 17,385 ========== ========== ========== -- -- -- December 31, January 31, February 28, 2001 2002 2002 ----------- ----------- ------------ ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals 48 -- -- Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups 1,000 461 164 Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL CURRENT ASSETS 1,048 461 164 PROPERTY, PLANT & EQUIPMENT, at cost -- -- -- Less: Accumulated depreciation and amortization -- -- -- ---------- ---------- ---------- NET PROPERTY, PLANT & EQUIPMENT 0 0 0 OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 15,908 15,424 15,721 ---------- ---------- ---------- 15,908 15,424 15,721 ---------- ---------- ---------- TOTAL ASSETS $ 16,956 $ 15,885 $ 15,885 ========== ========== ========== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 26,407 25,336 25,336 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- ---------- ---------- ---------- TOTAL LIABILITIES 26,407 25,336 25,336 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (8,847) (8,847) (8,847) Post filing date (604) (604) (604) ---------- ---------- ---------- (9,451) (9,451) (9,451) ---------- ---------- ---------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 16,956 $ 15,885 $ 15,885 ========== ========== ========== -- -- --
(1) Outstanding shares at December 31, 2001, January 31, 2002 and February 28, 2002 were 12,279,555. Comparative Balance Sheet Case Name: RESPONSE ONCOLOGY OF TAMARAC, INC. Case Number: 01-24610L Month of: February 2002 Statement of Income (Loss) (In Thousands)
April May June July August September 2001 2001 2001 2001 2001 2001 ----- ----- ----- ----- ------ --------- NET REVENUE $ 521 $ 683 $ 571 $ 564 $ 532 $ 427 COSTS AND EXPENSES Salaries and benefits 83 87 78 84 91 77 Pharmaceuticals and supplies 365 494 414 426 402 332 Other operating costs 33 57 31 26 28 23 General and administrative 51 55 45 57 48 43 Provision for doubtful accounts -- -- -- -- -- -- Loss on impairment of physician practices -- -- -- -- -- -- ----- ----- ----- ----- ----- ----- 532 693 568 593 569 475 ----- ----- ----- ----- ----- ----- EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA) (11) (10) 3 (29) (37) (48) Interest expense 2 3 2 3 2 2 Depreciation and amortization 14 14 14 14 14 14 ----- ----- ----- ----- ----- ----- LOSS BEFORE INCOME TAXES (27) (27) (13) (46) (53) (64) Income tax benefit (9) (9) (4) (17) (20) (26) ----- ----- ----- ----- ----- ----- NET LOSS $ (18) $ (18) $ (9) $ (29) $ (33) $ (38) ===== ===== ===== ===== ===== ===== October November December January February Filing 2001 2001 2001 2002 2002 To Date ------- -------- -------- ------- -------- -------- NET REVENUE $ 558 $ 516 $ 529 $ -- $ -- $ 4,901 COSTS AND EXPENSES Salaries and benefits 85 83 86 -- -- 754 Pharmaceuticals and supplies 394 386 536 -- -- 3,749 Other operating costs 30 29 14 -- -- 271 General and administrative 46 45 56 -- -- 446 Provision for doubtful accounts -- -- -- -- -- -- Loss on impairment of physician practices -- -- 256 -- -- 256 ----- ----- ----- ---- ------- -------- 555 543 948 -- -- 5,476 ----- ----- ----- ---- ------- -------- EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA) 3 (27) (419) -- -- (575) Interest expense 2 2 2 -- -- 20 Depreciation and amortization 14 8 8 -- -- 114 ----- ----- ----- ---- ------- -------- LOSS BEFORE INCOME TAXES (13) (37) (429) 0 0 (709) Income tax benefit (5) (15) -- -- -- (105) ----- ----- ----- ---- ------- -------- NET LOSS $ (8) $ (22) $(429) $ 0 $ 0 $ (604) ===== ===== ===== ==== ======= ========
Statement of Income (Loss) Case Name: RESPONSE ONCOLOGY OF TAMARAC, INC. Case Number: 01-24610L Month of: February 2002 -------------------------- (In Thousands) Statement of Cash Flows
Month Ended Month Ended Month Ended 4/30/2001 5/31/2001 6/30/2001 ----------- ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (18) (18) (9) Adjustments to reconcile net earnings from operations: Depreciation and amortization 14 14 14 Deferred income taxes -- -- -- Provision for losses on accounts receivable -- -- -- Loss on sale of property and equipment -- -- -- Impairment of MSAs and associated assets -- -- -- Changes in assets and liabilities: Accounts receivable -- -- -- Supplies, prepaid expenses, and other current assets (28) (59) 41 Deferred charges, other assets and intercompany receivable (payable) (388) 173 (82) Net advances to affiliated physician groups 420 (110) 36 Accounts payable and accrued expenses -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES -- -- -- INVESTING ACTIVITIES Proceeds from sale of property and equipment -- -- -- Purchase of equipment -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES -- -- -- FINANCING ACTIVITIES Principal payments on notes payable -- -- -- Principal payments on capital lease obligations -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES -- -- -- INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS -- -- -- Cash and cash equivalents at beginning of period -- -- -- ------ ------ ------ CASH AND CASH EQUIVALENTS AT END OF PERIOD $ -- $ -- $ -- ====== ====== ====== Month Ended Month Ended Month Ended 7/31/2001 8/31/2001 9/30/2001 ----------- ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (29) (33) (38) Adjustments to reconcile net earnings from operations: Depreciation and amortization 14 14 14 Deferred income taxes -- -- -- Provision for losses on accounts receivable -- -- -- Loss on sale of property and equipment 1 -- -- Impairment of MSAs and associated assets -- -- -- Changes in assets and liabilities: Accounts receivable -- -- -- Supplies, prepaid expenses, and other current assets 12 (8) (15) Deferred charges, other assets and intercompany receivable (payable) 5 (179) 89 Net advances to affiliated physician groups (3) 206 (48) Accounts payable and accrued expenses -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES -- -- 2 INVESTING ACTIVITIES Proceeds from sale of property and equipment -- -- -- Purchase of equipment -- -- (2) ------ ------ ------ NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES -- -- (2) FINANCING ACTIVITIES Principal payments on notes payable -- -- -- Principal payments on capital lease obligations -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES -- -- -- INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS -- -- -- Cash and cash equivalents at beginning of period -- -- -- ------ ------ ------ CASH AND CASH EQUIVALENTS AT END OF PERIOD $ -- $ -- $ -- ====== ====== ====== Month Ended Month Ended Month Ended 10/31/2001 11/30/2001 12/31/2001 ----------- ----------- ----------- OPERATING ACTIVITIES Net earnings (loss) (8) (22) (429) Adjustments to reconcile net earnings from operations: Depreciation and amortization 14 8 8 Deferred income taxes -- -- -- Provision for losses on accounts receivable -- -- -- Loss on sale of property and equipment -- -- -- Impairment of MSAs and associated assets -- -- 256 Changes in assets and liabilities: Accounts receivable -- -- -- Supplies, prepaid expenses, and other current assets (10) 27 6 Deferred charges, other assets and intercompany receivable (payable) 2,740 134 178 Net advances to affiliated physician groups (91) (19) Accounts payable and accrued expenses -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 2,645 147 -- INVESTING ACTIVITIES Proceeds from sale of property and equipment -- -- -- Purchase of equipment -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES -- -- -- FINANCING ACTIVITIES Principal payments on notes payable (2,645) (147) -- Principal payments on capital lease obligations -- -- -- ------ ------ ------ NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (2,645) (147) -- INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS -- -- -- Cash and cash equivalents at beginning of period -- -- -- ------ ------ ------ CASH AND CASH EQUIVALENTS AT END OF PERIOD $ -- $ -- $ -- ====== ====== ====== Month Ended Month Ended Filing 1/31/2002 2/28/2002 To Date ----------- ----------- -------- OPERATING ACTIVITIES Net earnings (loss) -- -- (604) Adjustments to reconcile net earnings from operations: Depreciation and amortization -- -- 114 Deferred income taxes -- -- -- Provision for losses on accounts receivable -- -- -- Loss on sale of property and equipment -- -- 1 Impairment of MSAs and associated assets -- -- 256 Changes in assets and liabilities: -- -- Accounts receivable -- -- -- Supplies, prepaid expenses, and other current assets 48 14 Deferred charges, other assets and intercompany receivable (payable) 484 (297) 2,857 Net advances to affiliated physician groups 539 297 1,227 Accounts payable and accrued expenses -- -- -------- ------ -------- NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 1,071 -- 3,865 INVESTING ACTIVITIES Proceeds from sale of property and equipment -- -- -- Purchase of equipment -- -- (2) -------- ------ -------- NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES -- -- (2) FINANCING ACTIVITIES Principal payments on notes payable (1,071) -- (3,863) Principal payments on capital lease obligations -- -- -- -------- ------ -------- NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (1,071) -- (3,863) INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS -- -- -- Cash and cash equivalents at beginning of period -- -- -- -------- ------ -------- CASH AND CASH EQUIVALENTS AT END OF PERIOD $ -- $ -- $ -- ======== ====== ========
Stmt of Cash Flows MONTHLY OPERATING REPORT COVER SHEET, CHECKLIST, & CERTIFICATE OF SERVICE UNITED STATES BANKRUPTCY COURT WESTERN DISTRICT OF TENNESSEE Case No.: 01-14609L In re: Response Oncology of ------------- ----------------------------- Ft. Lauderdale, Inc. Judge: David S. Kennedy ----------------------------- ---------------- Debtor(s) Chapter 11 MONTHLY OPERATING REPORT FOR MONTH ENDING February 28, 2002 COME(S) NOW, Response Oncology of Fort Lauderdale Inc. Debtor-In-Possession, and hereby submits its Monthly Operating Report for the period commencing February 1 and ending February 28 as shown by the report and exhibits consisting of 14 pages and containing the following as indicated: X Monthly Reporting Questionnaire (Attachment 1) --- X Comparative Balance Sheets (Forms OPR-1 & OPR-2) --- X Summary of Accounts Receivable (Form OPR-3) --- X Schedule of Postpetition Liabilities (Form OPR-4) --- X Statement of Income (Loss) (Form OPR-5) --- X Statement of Sources and Uses of Cash (Form OPR-6) --- X Certificate of Service --- ACCOUNTING METHOD USED: Cash --- X Accrual --- I declare under penalty of perjury that this Report and all attachments are true and correct to the best of my knowledge and belief. I also hereby certify that the original Monthly Operating Report was filed with the Bankruptcy Court Clerk and a file stamped copy delivered to the U.S. Trustee. Date: May 8, 2002 ----------- DEBTOR-IN-POSSESSION By: /s/ PETER A. STARK ---------------------------------------- (Signature) Name & Title: Peter A. Stark, CFO ----------------------------- (Print or Type) Address: 1805 Moriah Woods Blvd. ---------------------------------- Memphis, TN 38117 -------------------------------------------- Telephone Number: (901) 761-7000 --------------------------- ATTACHMENT 1 (PAGE 1 of 4) CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: RESPONSE ONCOLOGY OF FORT LAUDERDALE, INC. --------------------------------------------- CASE NUMBER: 01-24609L ------------------------------------------- MONTH OF: February 2002 ---------------------------------------------- 1. PAYROLL State the amount of all executive wages paid and taxes withheld and paid.
WAGES PAID TAXES ---------------------- ---------------------------- NAME AND TITLE OF EXECUTIVE GROSS NET AMOUNT DUE PAID - --------------------------- ------- ------- ------------ ---------- none - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- Total Executive Payroll: none ----------------------------------------------------------------------
2. INSURANCE Is workers' compensation and other insurance in effect? YES Are payments current? YES If any policy has lapsed, been replaced or renewed, so state in the schedule below. Attach a copy of the new policy's binder or cover page.
DATE COVERAGE EXPIRATION PREMIUM COVERAGE TYPE NAME OF CARRIER AMOUNT POLICY # DATE AMOUNT PD. THRU - ---- --------------- -------- -------- ---------- ------- -------- Casualty See Schedule 2 attached. ------------------------------------------------------------------------------------------------------------ Workers' comp. ------------------------------------------------------------------------------------------------------- General liab. ------------------------------------------------------------------------------------------------------- Vehicle -------------------------------------------------------------------------------------------------------------- Other (specify): ----------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------- REV 7/99
ATTACHMENT 1 (PAGE 2 of 4) CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: Response Oncology of Fort Lauderdale, Inc. ---------------------------------------------------- CASE NUMBER: 01-24609L -------------------------------------------------- MONTH OF: February, 2002 ----------------------------------------------------- 3. Bank Accounts
Account Type --------------------------------------------------------------------- Operating Tax Payroll Other Total --------- --------- --------- --------- --------- Bank name None None None None --------- --------- --------- --------- Account # --------- --------- --------- --------- Beginning book balance --------- --------- --------- --------- --------- Plus: Deposits (Attach detailed listing) --------- --------- --------- --------- --------- Less: Disbursements (Attach detailed listing) --------- --------- --------- --------- --------- Other: Transfers In (Out) ----0---- --------- --------- --------- --------- --------- Ending book balance --------- --------- --------- --------- ---------
4. Postpetition Payments. List any postpetition payments to professionals and payments on prepetition debts in the schedule below (attach a separate sheet if necessary).
Payments To/On Amount Date Check # Court Order Date - -------------- --------- --------- --------- ---------------- Professionals (attorneys, accountants, etc.): None - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- Prepetition debts: None - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ----------------
REV 7/99 ATTACHMENT 1 (PAGE 3 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF RECEIPTS CASE NAME: Response Oncology of Fort Lauderdale, Inc. -------------------------------------------- CASE NUMBER: 01-24609L ------------------------------------------ MONTH OF: February, 2002 -------------------------------------------- BANK NAME: None ACCOUNT #: ------------------------- ------------------------- Detail of Receipts:
Date Received From Explanation Amount - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- Total Receipts None *Must agree to "Deposits" line of Item 3 on Attachment 1 (Page 2). -------------------------- REV 7/99 (attach additional sheets if necessary)
ATTACHMENT 1 (PAGE 4 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF DISBURSEMENTS CASE NAME: Response Oncology of Fort Lauderdale, Inc. ---------------------------------------------- CASE NUMBER: 01-24609L -------------------------------------------- MONTH OF: February 2002 ----------------------------------------------- BANK NAME: None ACCOUNT #: -------------------------- -------------------------------- Detail of Disbursements:
Date Check # Paid To/In Payment Of Amount - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ----------
Total Disbursements None *Must agree to "Disbursements" line of Item --------------- 3 on Attachment 1 (Page 2). REV 7/99 (attach additional sheets if necessary) CASE NAME: RESPONSE ONCOLOGY, COMPARATIVE BALANCE SHEETS FORM OPR-1 -------------------------- OF FORT LAUDERDALE, INC. REV 7/99 -------------------------- CASE NUMBER: 01-24609L MONTH ENDED: February, 2002 --------------- ------------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------ ----- ----- ----- ----- ----- ----- ASSETS CURRENT ASSETS Cash See "Comparative Balance Sheets" attached. ----- ----- ----- ----- ----- ----- ----- Other negotiable instruments (i.e. CD's, Treasury bills, etc.) ----- ----- ----- ----- ----- ----- ----- Accounts receivable, net (See OPR-3) ----- ----- ----- ----- ----- ----- ----- Less allowance for doubtful accounts ----- ----- ----- ----- ----- ----- ----- Inventory, at lower of cost of Market ----- ----- ----- ----- ----- ----- ----- Prepaid expenses and deposits ----- ----- ----- ----- ----- ----- ----- Investments ----- ----- ----- ----- ----- ----- ----- Other ------------------------------------ ----- ----- ----- ----- ----- ----- ----- TOTAL CURRENT ASSETS ----- ----- ----- ----- ----- ----- ----- PROPERTY, PLANT & EQUIPMENT, AT COST ----- ----- ----- ----- ----- ----- ----- Less accumulated depreciation ----- ----- ----- ----- ----- ----- ----- NET PROPERTY, PLANT & EQUIPMENT ----- ----- ----- ----- ----- ----- ----- OTHER ASSETS ----- ----- ----- ----- ----- ----- ----- - ------------------------------------------- ----- ----- ----- ----- ----- ----- ----- TOTAL ASSETS ----- ----- ----- ----- ----- ----- -----
* Itemize on separate page if value of "Other Assets" exceeds 10% of "Total Assets". CASE NAME: Response Oncology of Fort Lauderdale, Inc. COMPARATIVE BALANCE SHEETS ------------------------------------------- FORM OPR-2 CASE NUMBER: 01-24609L MONTH ENDED: February, 2002 REV 7/99 ----------------------------------------- -----------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------------ --------- --------- --------- --------- --------- --------- LIABILITIES POST PETITION LIABILITIES (See OPR-4) -0- See "Comparative Balance Sheets" attached. --------- --------- --------- --------- --------- --------- PRE PETITION LIABILITIES Secured debt (petition Schedule D) ------------ --------- --------- --------- --------- --------- --------- Priority debt (petition Schedule E) ------------ --------- --------- --------- --------- --------- --------- Unsecured debt (petition Schedule F) ------------ --------- --------- --------- --------- --------- --------- TOTAL PRE PETITION LIABILITIES ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES ------------ --------- --------- --------- --------- --------- --------- SHAREHOLDERS' EQUITY (DEFICIT) PREFERRED STOCK ------------ --------- --------- --------- --------- --------- --------- COMMON STOCK ------------ --------- --------- --------- --------- --------- --------- PAID-IN CAPITAL ------------ --------- --------- --------- --------- --------- --------- RETAINED EARNINGS Through filing date ------------ --------- --------- --------- --------- --------- --------- Post filing date ------------ --------- --------- --------- --------- --------- --------- TOTAL SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- ---------
CASE NAME: Response Oncology of Fourth Lauderdale, Inc. SUMMARY OF ACCOUNTS RECEIVABLE FORM OPR-3 ---------------------------------------------------- REV 7/99 CASE NUMBER: 01-24609L MONTH ENDED: February, 2002 ---------------------------------------------------- ---------------
0-30 31-60 61-90 OVER TOTAL DAYS DAYS DAYS 90 DAYS DATE OF FILING: None ----------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ----------
NOTE: Total accounts receivable and total allowance for doubtful accounts shown here must agree with the same items as shown on Form OPR-1. FORM OPR-4 REV 7/99 SCHEDULE OF POST PETITION LIABILITIES CASE NAME: Response Oncology of Fort Lauderdale, Inc. -------------------------------------------- CASE NUMBER: 01-24609L MONTH ENDED: February, 2002 ------------------------------ ---------------
DATE DATE TOTAL 0-30 31-60 61-90 OVER INCURRED DUE DUE DAYS DAYS DAYS 90 DAYS -------- -------- -------- -------- -------- -------- -------- TAXES PAYABLE Federal Income Tax None -------- -------- -------- -------- -------- -------- -------- FICA -------- -------- -------- -------- -------- -------- -------- Unemployment Tax -------- -------- -------- -------- -------- -------- -------- Sales Tax -------- -------- -------- -------- -------- -------- -------- Personal Property Tax -------- -------- -------- -------- -------- -------- -------- TOTAL TAXES PAYABLE -------- -------- -------- -------- -------- -------- -------- POSTPETITION SECURED DEBT -------- -------- -------- -------- -------- -------- -------- POSTPETITION UNSECURED DEBT -------- -------- -------- -------- -------- -------- -------- ACCRUED INTEREST PAYABLE -------- -------- -------- -------- -------- -------- -------- TRADE ACCOUNTS PAYABLE & OTHER: (list separately*) -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- TOTALS None -------- -------- -------- -------- -------- -------- --------
*Attach separate page if necessary NOTE: Total postpetition liabilities shown here must agree with the same item as shown on Form OPR-2 of this report. CASE NAME: Response Oncology of Fort Lauderdale, Inc. STATEMENT OF INCOME (LOSS) FORM OPR-5 ------------------------------- REV 7/99 CASE NUMBER: 01-24609L MONTH ENDED: February, 2002 ------------------------------- ----------------
FILING MONTH MONTH MONTH MONTH MONTH MONTH TO DATE None --------- --------- --------- --------- --------- ---------- ---------- NET REVENUE (INCOME) --------- --------- --------- --------- --------- ---------- ---------- COST OF GOODS SOLD Materials --------- --------- --------- --------- --------- ---------- ---------- Labor - Direct --------- --------- --------- --------- --------- ---------- ---------- Manufacturing Overhead --------- --------- --------- --------- --------- ---------- ---------- TOTAL COST OF GOODS SOLD --------- --------- --------- --------- --------- ---------- ---------- GROSS PROFIT --------- --------- --------- --------- --------- ---------- ---------- OPERATING EXPENSES Selling and Marketing --------- --------- --------- --------- --------- ---------- ---------- General and Administrative --------- --------- --------- --------- --------- ---------- ---------- Other:__________________ --------- --------- --------- --------- --------- ---------- ---------- TOTAL OPERATING EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INCOME BEFORE INTEREST, DEPRECIATION, TAXES OR EXTRAORDINARY EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INTEREST EXPENSE --------- --------- --------- --------- --------- ---------- ---------- DEPRECIATION --------- --------- --------- --------- --------- ---------- ---------- INCOME TAX EXPENSE (BENEFIT) --------- --------- --------- --------- --------- ---------- ---------- EXTRAORDINARY INCOME (EXPENSE)* --------- --------- --------- --------- --------- ---------- ---------- NET INCOME (LOSS) None --------- --------- --------- --------- --------- ---------- ----------
* Requires Footnote STATEMENT OF SOURCES AND USES OF CASH CASE NAME: Response Oncology of Fort Lauderdale, Inc. ----------------------------------------------------- FORM OPR-6 CASE NUMBER: 01-24609L MONTH ENDED: February, 2002 REV 7/99 --------------------------------------------------- ---------------
MONTH MONTH MONTH MONTH MONTH MONTH --------- --------- --------- --------- --------- --------- None --------- --------- --------- --------- --------- --------- SOURCES OF CASH Income (Loss) From Operations Add: Depreciation, Amortization & Other Non-Cash Items --------- --------- --------- --------- --------- --------- CASH GENERATED FROM OPERATIONS --------- --------- --------- --------- --------- --------- Add: Decrease in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Increase in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL SOURCES OF CASH (A) --------- --------- --------- --------- --------- --------- USES OF CASH Increase in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Decrease in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL USES OF CASH (B) --------- --------- --------- --------- --------- --------- NET SOURCE (USE) OF CASH (A-B=NET) --------- --------- --------- --------- --------- --------- CASH - BEGINNING BALANCE (OPR-1) --------- --------- --------- --------- --------- --------- CASH - ENDING BALANCE (OPR-1) --------- --------- --------- --------- --------- ---------
CERTIFICATE OF SERVICE I hereby certify that a true copy of the foregoing Monthly Operating Report was sent by U.S. Mail properly addressed and with correct postage (or hand delivered) to the persons or offices listed below. Done this day of , 19 . ------ --------------- ---- ---------------------------------- (Signature) ---------------------------------- (Printed name) ---------------------------------- (Street address) ---------------------------------- (City, state, zip) ---------------------------------- (Telephone) ORIGINAL FILED WITH: U.S. Bankruptcy Court - ---------------------------------------- (Address) - ---------------------------------------- (City, state, zip) - ---------------------------------------- (Date) FILE STAMPED COPIES MAILED TO: U.S. Trustee One Memphis Place 200 Jefferson Avenue, Suite 400 Memphis, TN 38103 Members of Creditors Committee (if applicable list names and addresses on separate sheet) List any other interested parties to whom MOR was issued: Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK/01-24610L/01-24609L/01-24608B Month of: February 2002 2. Insurance
- ----------------------------------------------------------------------------------------------------------------------------------- POLICY TYPE INSURANCE COMPANY - ----------------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" Hartford Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Crime Insurance Federal Insurance Company (Chubb) - ----------------------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime Federal Insurance Company (Chubb) - ----------------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability Steadfast Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Automobile Liability Hartford Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Property Lexington Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Property Royal Indemnity Insurance - ----------------------------------------------------------------------------------------------------------------------------------- Property TIG Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability Hartford Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability Gulf Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Umbrella Liability Chicago Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- General Liability Chicago Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability Chicago Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) Reliance Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability Zurich Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery Continental Insurance Company - ----------------------------------------------------------------------------------------------------------------------------------- Florida Windstorm Florida Windstorm Underwriting Association - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- POLICY TYPE COVERAGE AMOUNT POLICY NUMBER - ----------------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" 500,000 20WBEX6471 - ----------------------------------------------------------------------------------------------------------------------------------- Crime Insurance 1,000,000 81514719A - ----------------------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime 1,000,000 81514719A - ----------------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability 1,000,000/3,000,000 APL360208302 - ----------------------------------------------------------------------------------------------------------------------------------- Automobile Liability 1,000,000 20UENUW8330 - ----------------------------------------------------------------------------------------------------------------------------------- Property 1,000,000 1280081 - ----------------------------------------------------------------------------------------------------------------------------------- Property 4,000,000 RHD319956 - ----------------------------------------------------------------------------------------------------------------------------------- Property 12,275,770 XPT39245522 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability 5,000,000 NDA013978800 - ----------------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability 5,000,000 GA0689336 - ----------------------------------------------------------------------------------------------------------------------------------- Umbrella Liability 5,000,000/5,000,000 XSC2000073 - ----------------------------------------------------------------------------------------------------------------------------------- General Liability 1,000,000/3,000,000 GLI1038480 - ----------------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability 1,000,000/3,000,000 HCC2001017 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) 10,000,000 NDA0142699-97 - ----------------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability 1,000,000 EOC3618914-03 - ----------------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery 5,000,000 BM1098379645 - ----------------------------------------------------------------------------------------------------------------------------------- Florida Windstorm 850,000 1237949 - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- POLICY TYPE EXPIRATION DATE PREMIUM DESCRIPTION - ----------------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" 8/1/2002 Estimated Ann. Prem. - ----------------------------------------------------------------------------------------------------------------------------------- Crime Insurance 2/1/2002 Semi Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime 2/1/2002 Semi Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability 2/1/2002 Semi Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Automobile Liability 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Property 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Property 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Property 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability 6/30/2002 Semi Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability 3/31/2002 Semi Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Umbrella Liability 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- General Liability 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) 12/1/2003 Prepaid - ----------------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- Florida Windstorm 8/1/2002 Annual Premium - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- DATE COVERAGE POLICY TYPE PREMIUM AMOUNTS PAID THROUGH - ----------------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" 44,441 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Crime Insurance 3,000 2/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime 2,075 2/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability 97,375 2/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Automobile Liability 3,959 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Property 106,592 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Property 15,000 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Property 25,000 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability 75,384 6/30/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability 57,812 3/31/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Umbrella Liability 174,269 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- General Liability 3,320 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability 142,219 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) 90,000 12/1/2003 - ----------------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability 25,895 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery 3,585 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Florida Windstorm 3,801 8/1/2002 - -----------------------------------------------------------------------------------------------------------------------------------
Schedule 2 Insurance Case Name: RESPONSE ONCOLOGY OF FT. LAUDERDALE, INC. Case Number: 01-24609L Month of: February 2002 (In Thousands) Comparative Balance Sheets
Filing Date March 29, April 30, May 31, 2001 2001 2001 ----------- --------- -------- ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals -- -- -- Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL CURRENT ASSETS -- -- -- PROPERTY, PLANT & EQUIPMENT, at cost -- -- -- Less: Accumulated depreciation and amortization -- -- -- -------- -------- -------- NET PROPERTY, PLANT & EQUIPMENT -- -- -- OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 23,435 23,435 23,435 -------- -------- -------- 23,435 23,435 23,435 -------- -------- -------- TOTAL ASSETS $ 23,435 $ 23,435 $ 23,435 ======== ======== ======== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 29,199 29,199 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL LIABILITIES 29,199 29,199 29,199 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (5,764) (5,764) (5,764) Post filing date -- -- -- -------- -------- -------- (5,764) (5,764) (5,764) -------- -------- -------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 23,435 $ 23,435 $ 23,435 ======== ======== ======== -- -- -- June 30, July 31, August 31, 2001 2001 2001 --------- --------- ---------- ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals -- -- -- Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL CURRENT ASSETS -- -- -- PROPERTY, PLANT & EQUIPMENT, at cost -- -- -- Less: Accumulated depreciation and amortization -- -- -- -------- -------- -------- NET PROPERTY, PLANT & EQUIPMENT -- -- -- OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 23,435 23,435 23,435 -------- -------- -------- 23,435 23,435 23,435 -------- -------- -------- TOTAL ASSETS $ 23,435 $ 23,435 $ 23,435 ======== ======== ======== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 29,199 29,199 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL LIABILITIES 29,199 29,199 29,199 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (5,764) (5,764) (5,764) Post filing date -- -- -- -------- -------- -------- (5,764) (5,764) (5,764) -------- -------- -------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 23,435 $ 23,435 $ 23,435 ======== ======== ======== -- -- -- September 30, October 31, November 30, 2001 2001 2001 ------------- ----------- ------------ ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals -- -- -- Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL CURRENT ASSETS -- -- -- PROPERTY, PLANT & EQUIPMENT, at cost -- -- -- Less: Accumulated depreciation and amortization -- -- -- -------- -------- -------- NET PROPERTY, PLANT & EQUIPMENT -- -- -- OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 23,435 20,790 20,643 -------- -------- -------- 23,435 20,790 20,643 -------- -------- -------- TOTAL ASSETS $ 23,435 $ 20,790 $ 20,643 ======== ======== ======== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 26,554 26,407 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL LIABILITIES 29,199 26,554 26,407 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (5,764) (5,764) (5,764) Post filing date -- -- -- -------- -------- -------- (5,764) (5,764) (5,764) -------- -------- -------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 23,435 $ 20,790 $ 20,643 ======== ======== ======== -- -- -- December 31, January 31, February 28, 2001 2002 2002 ------------ ----------- ------------ ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- Accounts receivable -- -- -- Less: Allowance for doubtful accounts -- -- -- Supplies and pharmaceuticals -- -- -- Prepaid expenses and other current assets -- -- -- Due from affiliated physician groups -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL CURRENT ASSETS -- -- -- PROPERTY, PLANT & EQUIPMENT, at cost -- -- -- Less: Accumulated depreciation and amortization -- -- -- -------- -------- -------- NET PROPERTY, PLANT & EQUIPMENT -- -- -- OTHER ASSETS Deferred charges -- -- -- Less: Accumulated amortization, deferred charges -- -- -- Management service agreements -- -- -- Less: Accumulated amortization, management service agreements -- -- -- Other assets -- -- -- Intercompany receivable (payable) 20,643 19,572 19,572 -------- -------- -------- 20,643 19,572 19,572 -------- -------- -------- TOTAL ASSETS $ 20,643 $ 19,572 $ 19,572 ======== ======== ======== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- Pre-petition liabilities: Secured debt 26,407 25,336 25,336 Priority debt -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- Subordinated notes payable -- -- -- Capital lease obligations -- -- -- Other GAAP accruals not included in schedules -- -- -- Deferred income taxes -- -- -- -------- -------- -------- TOTAL LIABILITIES 26,407 25,336 25,336 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- Paid-in capital -- -- -- Accumulated deficit: Through filing date (5,764) (5,764) (5,764) Post filing date -- -- -- -------- -------- -------- (5,764) (5,764) (5,764) -------- -------- -------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 20,643 $ 19,572 $ 19,572 ======== ======== ======== -- -- --
(1) Outstanding shares at December 31, 2001, January 31, 2002 and February 28, 2002 were 12,279,555. Comparative Balance Sheets MONTHLY OPERATING REPORT COVER SHEET, CHECKLIST, & CERTIFICATE OF SERVICE UNITED STATES BANKRUPTCY COURT WESTERN DISTRICT OF TENNESSEE Case No.: 01-24608B In re: Response Oncology Management of ------------- ----------------------------------- South Florida, Inc. Judge: David S. Kennedy ----------------------------------- ---------------- Debtor(s) Chapter 11 MONTHLY OPERATING REPORT FOR MONTH ENDING February 28, 2002 COME(S) NOW. Response Oncology Management of South Florida, Inc. Debtor-In-Possession, and hereby submits its Monthly Operating Report for the period commencing February 1 and ending February 28 as shown by the report and exhibits consisting of 14 pages and containing the following as indicated: X Monthly Reporting Questionnaire (Attachment 1) --- X Comparative Balance Sheets (Forms OPR-1 & OPR-2) --- X Summary of Accounts Receivable (Form OPR-3) --- X Schedule of Postpetition Liabilities (Form OPR-4) --- X Statement of Income (Loss) (Form OPR-5) --- X Statement of Sources and Uses of Cash (Form OPR-6) --- X Certificate of Service --- ACCOUNTING METHOD USED: Cash --- X Accrual --- I declare under penalty of perjury that this Report and all attachments are true and correct to the best of my knowledge and belief. I also hereby certify that the original Monthly Operating Report was filed with the Bankruptcy Court Clerk and a file stamped copy delivered to the U.S. Trustee. Date: May 8, 2002 ----------- DEBTOR-IN-POSSESSION By: /s/ Peter A. Stark ---------------------------------------- (Signature) Name & Title: Peter A. Stark, CFO ----------------------------- (Print or Type) Address: 1805 Moriah Woods Blvd. ---------------------------------- Memphis, TN 38117 -------------------------------------------- Telephone Number: (901) 761-7000 --------------------------- REV 7/99 ATTACHMENT 1 (PAGE 1 of CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: RESPONSE ONCOLOGY MANAGEMENT OF SOUTH FLORIDA, INC. ----------------------------------------------------- CASE NUMBER: 01-24608B --------------------------------------------------- MONTH OF: February 2002 ------------------------------------------------------ 1. PAYROLL State the amount of all executive wages paid and taxes withheld and paid.
WAGES PAID TAXES ---------------------- ---------------------------- NAME AND TITLE OF EXECUTIVE GROSS NET AMOUNT DUE PAID - --------------------------- ------- ------- ------------ ---------- none - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------- Total Executive Payroll: none ----------------------------------------------------------------------
2. INSURANCE Is workers' compensation and other insurance in effect? YES Are payments current? YES If any policy has lapsed, been replaced or renewed, so state in the schedule below. Attach a copy of the new policy's binder or cover page.
DATE COVERAGE EXPIRATION PREMIUM COVERAGE TYPE NAME OF CARRIER AMOUNT POLICY # DATE AMOUNT PD. THRU - ---- --------------- -------- -------- ---------- ------- -------- Casualty See Schedule 2 attached. ------------------------------------------------------------------------------------------------------------ Workers' comp. ------------------------------------------------------------------------------------------------------- General liab. ------------------------------------------------------------------------------------------------------- Vehicle -------------------------------------------------------------------------------------------------------------- Other (specify): ----------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------- REV 7/99
ATTACHMENT 1 (PAGE 2 of 4) CHAPTER 11 MONTHLY OPERATING REPORT MONTHLY REPORTING QUESTIONNAIRE CASE NAME: Response Oncology Management of South Florida, Inc. ---------------------------------------------------- CASE NUMBER: 01-24608B -------------------------------------------------- MONTH OF: February, 2002 ----------------------------------------------------- 3. Bank Accounts
Account Type --------------------------------------------------------------------- Operating Tax Payroll Other Total --------- --------- --------- --------- --------- Bank name None None None None --------- --------- --------- --------- Account # --------- --------- --------- --------- Beginning book balance --------- --------- --------- --------- --------- Plus: Deposits (Attach detailed listing) --------- --------- --------- --------- --------- Less: Disbursements (Attach detailed listing) --------- --------- --------- --------- --------- Other: Transfers In (Out) ----0---- --------- --------- --------- --------- --------- Ending book balance --------- --------- --------- --------- ---------
4. Postpetition Payments. List any postpetition payments to professionals and payments on prepetition debts in the schedule below (attach a separate sheet if necessary).
Payments To/On Amount Date Check # Court Order Date - -------------- --------- --------- --------- ---------------- Professionals (attorneys, accountants, etc.): None - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- Prepetition debts: None - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ---------------- - --------------------------------------------- --------- --------- --------- ----------------
REV 7/99 ATTACHMENT 1 (PAGE 3 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF RECEIPTS CASE NAME: Response Oncology Management of South Florida, Inc. ----------------------------------------------------- CASE NUMBER: 01-24608B --------------------------------------------------- MONTH OF: February, 2002 ----------------------------------------------------- BANK NAME: None ACCOUNT #: ------------------------- ------------------------- Detail of Receipts:
Date Received From Explanation Amount - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- - --------- -------------------------- -------------------------- -------------------------- Total Receipts None *Must agree to "Deposits" line of Item 3 on Attachment 1 (Page 2). -------------------------- REV 7/99 (attach additional sheets if necessary)
ATTACHMENT 1 (PAGE 4 of 4) CHAPTER 11 MONTHLY OPERATING REPORT DETAILED LISTING OF DISBURSEMENTS CASE NAME: Response Oncology Management of South Florida, Inc. ----------------------------------------------------- CASE NUMBER: 01-24608B --------------------------------------------------- MONTH OF: February 2002 ------------------------------------------------------ BANK NAME: None ACCOUNT #: -------------------------- -------------------------------- Detail of Disbursements:
Date Check # Paid To/In Payment Of Amount - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ---------- - --------- ---------- ------------------------------- ----------
Total Disbursements None *Must agree to "Disbursements" line of Item --------------- 3 on Attachment 1 (Page 2). REV 7/99 (attach additional sheets if necessary) CASE NAME: Response Oncology COMPARATIVE BALANCE SHEETS FORM OPR-1 ---------------------- REV 7/99 Management of ---------------------- South Florida, Inc. ---------------------- CASE NUMBER: 01-24608B MONTH ENDED: February, 2002 -------------------- --------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------ ----- ----- ----- ----- ----- ----- ASSETS CURRENT ASSETS Cash See "Comparative Balance Sheets" attached. ----- ----- ----- ----- ----- ----- ----- Other negotiable instruments (i.e. CD's, Treasury bills, etc.) ----- ----- ----- ----- ----- ----- ----- Accounts receivable, net (See OPR-3) ----- ----- ----- ----- ----- ----- ----- Less allowance for doubtful accounts ----- ----- ----- ----- ----- ----- ----- Inventory, at lower of cost of market ----- ----- ----- ----- ----- ----- ----- Prepaid expenses and deposits ----- ----- ----- ----- ----- ----- ----- Investments ----- ----- ----- ----- ----- ----- ----- Other ------------------------------------ ----- ----- ----- ----- ----- ----- ----- TOTAL CURRENT ASSETS ----- ----- ----- ----- ----- ----- ----- PROPERTY, PLANT & EQUIPMENT, AT COST ----- ----- ----- ----- ----- ----- ----- Less accumulated depreciation ----- ----- ----- ----- ----- ----- ----- NET PROPERTY, PLANT & EQUIPMENT ----- ----- ----- ----- ----- ----- ----- OTHER ASSETS ----- ----- ----- ----- ----- ----- ----- - ------------------------------------------- ----- ----- ----- ----- ----- ----- ----- TOTAL ASSETS ----- ----- ----- ----- ----- ----- -----
* Itemize on separate page if value of "Other Assets" exceeds 10% of "Total Assets". CASE NAME: Response Oncology Management of COMPARATIVE BALANCE SHEETS ----------------------------------- FORM OPR-2 South Florida, Inc. REV 7/99 CASE NUMBER: 01-24608B MONTH ENDED: February, 2002 --------------------------------- -----------------
FILING DATE MONTH MONTH MONTH MONTH MONTH MONTH ------------ --------- --------- --------- --------- --------- --------- LIABILITIES POST PETITION LIABILITIES (See OPR-4) -0- See "Comparative Balance Sheets" attached. --------- --------- --------- --------- --------- --------- PRE PETITION LIABILITIES Secured debt (petition Schedule D) ------------ --------- --------- --------- --------- --------- --------- Priority debt (petition Schedule E) ------------ --------- --------- --------- --------- --------- --------- Unsecured debt (petition Schedule F) ------------ --------- --------- --------- --------- --------- --------- TOTAL PRE PETITION LIABILITIES ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES ------------ --------- --------- --------- --------- --------- --------- SHAREHOLDERS' EQUITY (DEFICIT) PREFERRED STOCK ------------ --------- --------- --------- --------- --------- --------- COMMON STOCK ------------ --------- --------- --------- --------- --------- --------- PAID-IN CAPITAL ------------ --------- --------- --------- --------- --------- --------- RETAINED EARNINGS Through filing date ------------ --------- --------- --------- --------- --------- --------- Post filing date ------------ --------- --------- --------- --------- --------- --------- TOTAL SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- --------- TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY ------------ --------- --------- --------- --------- --------- ---------
CASE NAME: Response Oncology Management of South Florida, Inc. SUMMARY OF ACCOUNTS RECEIVABLE FORM OPR-3 ---------------------------------------------------- REV 7/99 CASE NUMBER: 01-24608B MONTH ENDED: February, 2002 ---------------------------------------------------- --------------
0-30 31-60 61-90 OVER TOTAL DAYS DAYS DAYS 90 DAYS DATE OF FILING: None ----------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ---------- MONTH: --------------------------- ---------- ---------- ---------- ---------- ---------- Allowance for doubtful accounts ( ) ( ) ( ) ( ) ( ) ---------- ---------- ---------- ---------- ----------
NOTE: Total accounts receivable and total allowance for doubtful accounts shown here must agree with the same items as shown on Form OPR-1. FORM OPR-4 REV 7/99 SCHEDULE OF POST PETITION LIABILITIES CASE NAME: Response Oncology Management of South Florida, Inc. ------------------------------------------------------ CASE NUMBER: 01-24608-B MONTH ENDED: February, 2002 ------------------------------ ---------------
DATE DATE TOTAL 0-30 31-60 61-90 OVER INCURRED DUE DUE DAYS DAYS DAYS 90 DAYS -------- -------- -------- -------- -------- -------- -------- TAXES PAYABLE Federal Income Tax None -------- -------- -------- -------- -------- -------- -------- FICA -------- -------- -------- -------- -------- -------- -------- Unemployment Tax -------- -------- -------- -------- -------- -------- -------- Sales Tax -------- -------- -------- -------- -------- -------- -------- Personal Property Tax -------- -------- -------- -------- -------- -------- -------- TOTAL TAXES PAYABLE -------- -------- -------- -------- -------- -------- -------- POSTPETITION SECURED DEBT -------- -------- -------- -------- -------- -------- -------- POSTPETITION UNSECURED DEBT -------- -------- -------- -------- -------- -------- -------- ACCRUED INTEREST PAYABLE -------- -------- -------- -------- -------- -------- -------- TRADE ACCOUNTS PAYABLE & OTHER: (list separately*) -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- - ------------------------------ -------- -------- -------- -------- -------- -------- -------- TOTALS None -------- -------- -------- -------- -------- -------- --------
*Attach separate page if necessary NOTE: Total postpetition liabilities shown here must agree with the same item as shown on Form OPR-2 of this report. CASE NAME: Response Oncology Management of STATEMENT OF INCOME (LOSS) FORM OPR-5 South Florida, Inc. REV 7/99 ------------------------------- CASE NUMBER: 01-24608B MONTH ENDED: February, 2002 ------------------------------- ----------------
FILING MONTH MONTH MONTH MONTH MONTH MONTH TO DATE None --------- --------- --------- --------- --------- ---------- ---------- NET REVENUE (INCOME) --------- --------- --------- --------- --------- ---------- ---------- COST OF GOODS SOLD Materials --------- --------- --------- --------- --------- ---------- ---------- Labor - Direct --------- --------- --------- --------- --------- ---------- ---------- Manufacturing Overhead --------- --------- --------- --------- --------- ---------- ---------- TOTAL COST OF GOODS SOLD --------- --------- --------- --------- --------- ---------- ---------- GROSS PROFIT --------- --------- --------- --------- --------- ---------- ---------- OPERATING EXPENSES Selling and Marketing --------- --------- --------- --------- --------- ---------- ---------- General and Administrative --------- --------- --------- --------- --------- ---------- ---------- Other:__________________ --------- --------- --------- --------- --------- ---------- ---------- TOTAL OPERATING EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INCOME BEFORE INTEREST, DEPRECIATION, TAXES OR EXTRAORDINARY EXPENSES --------- --------- --------- --------- --------- ---------- ---------- INTEREST EXPENSE --------- --------- --------- --------- --------- ---------- ---------- DEPRECIATION --------- --------- --------- --------- --------- ---------- ---------- INCOME TAX EXPENSE (BENEFIT) --------- --------- --------- --------- --------- ---------- ---------- EXTRAORDINARY INCOME (EXPENSE)* --------- --------- --------- --------- --------- ---------- ---------- NET INCOME (LOSS) None --------- --------- --------- --------- --------- ---------- ----------
* Requires Footnote STATEMENT OF SOURCES AND USES OF CASH CASE NAME: Response Oncology Management of South Florida, Inc. ----------------------------------------------------- FORM OPR-6 CASE NUMBER: 01-24608B MONTH ENDED: February, 2002 REV 7/99 --------------------------------------------------- ---------------
MONTH MONTH MONTH MONTH MONTH MONTH --------- --------- --------- --------- --------- --------- None --------- --------- --------- --------- --------- --------- SOURCES OF CASH Income (Loss) From Operations Add: Depreciation, Amortization & Other Non-Cash Items --------- --------- --------- --------- --------- --------- CASH GENERATED FROM OPERATIONS --------- --------- --------- --------- --------- --------- Add: Decrease in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Increase in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL SOURCES OF CASH (A) --------- --------- --------- --------- --------- --------- USES OF CASH Increase in Assets: Accounts Receivable --------- --------- --------- --------- --------- --------- Inventory --------- --------- --------- --------- --------- --------- Prepaid Expenses & Deposits --------- --------- --------- --------- --------- --------- Property, Plant & Equipment --------- --------- --------- --------- --------- --------- Other --------- --------- --------- --------- --------- --------- Decrease in Liabilities: Pre Petition Liabilities --------- --------- --------- --------- --------- --------- Post Petition Liabilities --------- --------- --------- --------- --------- --------- TOTAL USES OF CASH (B) --------- --------- --------- --------- --------- --------- NET SOURCE (USE) OF CASH (A-B=NET) --------- --------- --------- --------- --------- --------- CASH - BEGINNING BALANCE (OPR-1) --------- --------- --------- --------- --------- --------- CASH - ENDING BALANCE (OPR-1) --------- --------- --------- --------- --------- ---------
CERTIFICATE OF SERVICE I hereby certify that a true copy of the foregoing Monthly Operating Report was sent by U.S. Mail properly addressed and with correct postage (or hand delivered) to the persons or offices listed below. Done this day of , 19 . ------ --------------- ---- ---------------------------------- (Signature) ---------------------------------- (Printed name) ---------------------------------- (Street address) ---------------------------------- (City, state, zip) ---------------------------------- (Telephone) ORIGINAL FILED WITH: U.S. Bankruptcy Court - ---------------------------------------- (Address) - ---------------------------------------- (City, state, zip) - ---------------------------------------- (Date) FILE STAMPED COPIES MAILED TO: U.S. Trustee One Memphis Place 200 Jefferson Avenue, Suite 400 Memphis, TN 38103 Members of Creditors Committee (if applicable list names and addresses on separate sheet) List any other interested parties to whom MOR was issued: Case Name: RESPONSE ONCOLOGY, INC., et al. Case Number: 01-24607-DSK/01-24610L/01-24609L/01-24608B Month of: February 2002 2. INSURANCE
- ----------------------------------------------------------------------------------------------------------------------------------- POLICY TYPE INSURANCE COMPANY COVERAGE AMOUNT - ----------------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" Hartford Insurance Company 500,000 - ----------------------------------------------------------------------------------------------------------------------------------- Crime Insurance Federal Insurance Company (Chubb) 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Fiduciary Liability/Crime Federal Insurance Company (Chubb) 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability Steadfast Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Automobile Liability Hartford Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Property Lexington Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Property Royal Indemnity Insurance 4,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Property TIG Insurance Company 12,275,770 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability Hartford Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability Gulf Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Umbrella Liability Chicago Insurance Company 5,000,000/5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- General Liability Chicago Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability Chicago Insurance Company 1,000,000/3,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) Reliance Insurance Company 10,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability Zurich Insurance Company 1,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery Continental Insurance Company 5,000,000 - ----------------------------------------------------------------------------------------------------------------------------------- Florida Windstorm Florida Windstorm Underwriting Association 850,000 - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- EXPIRATION PREMIUM PREMIUM DATE COVERAGE POLICY TYPE POLICY NUMBER DATE DESCRIPTION AMOUNTS PAID THROUGH - ----------------------------------------------------------------------------------------------------------------------------------- Workers Compensation/Employers Liability "All States" 20WBEX6471 8/1/2002 Estimated Ann. Prem. 44,441 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Crime Insurance 2/1/2002 Semi Annual Premium 3,000 2/1/2002 - ------------------------------------------------------- 81514719A ----------------------------------------------------------------- Fiduciary Liability/Crime 2/1/2002 Semi Annual Premium 2,075 2/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Managed Care Professional Liability APL360208302 2/1/2002 Semi Annual Premium 97,375 2/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Automobile Liability 20UENUW8330 8/1/2002 Annual Premium 3,959 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Property 1280081 8/1/2002 Annual Premium 106,592 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Property RHD319956 8/1/2002 Annual Premium 15,000 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Property XPT39245522 8/1/2002 Annual Premium 25,000 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability NDA013978800 6/30/2002 Semi Annual Premium 75,384 6/30/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Excess Directors and Officers Liability GA0689336 3/31/2002 Semi Annual Premium 57,812 3/31/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Umbrella Liability XSC2000073 8/1/2002 Annual Premium 174,269 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- General Liability GLI1038480 8/1/2002 Annual Premium 3,320 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Hospital Professional Liability/General Liability HCC2001017 8/1/2002 Annual Premium 142,219 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Directors and Officers Liability (Tail Coverage) NDA0142699-97 12/1/2003 Prepaid 90,000 12/1/2003 - ----------------------------------------------------------------------------------------------------------------------------------- Employment Practices Liability EOC3618914-03 8/1/2002 Annual Premium 25,895 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Boiler & Machinery BM1098379645 8/1/2002 Annual Premium 3,585 8/1/2002 - ----------------------------------------------------------------------------------------------------------------------------------- Florida Windstorm 1237949 8/1/2002 Annual Premium 3,801 8/1/2002 - -----------------------------------------------------------------------------------------------------------------------------------
SCHEDULE 2 INSURANCE Case Name: RESPONSE ONCOLOGY MANAGEMENT OF SOUTH FLORIDA, INC. Case Number: 01-24608B Month of: February 2002 (In Thousands) Comparative Balance Sheets
Filing Date March 29, April 30, May 31, June 30, July 31, August 31, 2001 2001 2001 2001 2001 2001 ----------- --------- -------- -------- -------- --------- ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- $ -- $ -- $ -- Accounts receivable -- -- -- -- -- -- Less: Allowance for doubtful accounts -- -- -- -- -- -- Supplies and pharmaceuticals -- -- -- -- -- -- Prepaid expenses and other current assets -- -- -- -- -- -- Due from affiliated physician groups -- -- -- -- -- -- Deferred income taxes -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- TOTAL CURRENT ASSETS -- -- -- -- -- -- PROPERTY, PLANT & EQUIPMENT, at cost -- -- -- -- -- -- Less: Accumulated depreciation and amortization -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- NET PROPERTY, PLANT & EQUIPMENT -- -- -- -- -- -- OTHER ASSETS Deferred charges -- -- -- -- -- -- Less: Accumulated amortization, deferred charges -- -- -- -- -- -- Management service agreements -- -- -- -- -- -- Less: Accumulated amortization, management service agreements -- -- -- -- -- -- Other assets -- -- -- -- -- -- Intercompany receivable (payable) 28,430 28,430 28,430 28,430 28,430 28,430 -------- -------- -------- -------- -------- -------- 28,430 28,430 28,430 28,430 28,430 28,430 -------- -------- -------- -------- -------- -------- TOTAL ASSETS $ 28,430 $ 28,430 $ 28,430 $ 28,430 $ 28,430 $ 28,430 ======== ======== ======== ======== ======== ======== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 29,199 29,199 29,199 29,199 29,199 Priority debt -- -- -- -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- -- -- -- Subordinated notes payable -- -- -- -- -- -- Capital lease obligations -- -- -- -- -- -- Other GAAP accruals not included in schedules -- -- -- -- -- -- Deferred income taxes -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- TOTAL LIABILITIES 29,199 29,199 29,199 29,199 29,199 29,199 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- -- -- -- Paid-in capital -- -- -- -- -- -- Accumulated deficit: Through filing date (769) (769) (769) (769) (769) (769) Post filing date -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- (769) (769) (769) (769) (769) (769) -------- -------- -------- -------- -------- -------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 28,430 $ 28,430 $ 28,430 $ 28,430 $ 28,430 $ 28,430 ======== ======== ======== ======== ======== ======== September 30, October 31, November 30, December 31, January 31, February 28, 2001 2001 2001 2001 2002 2002 ------------- ----------- ------------ ------------ ----------- ------------ ASSETS CURRENT ASSETS Cash and cash equivalents $ -- $ -- $ -- $ -- $ -- $ -- Accounts receivable -- -- -- -- -- -- Less: Allowance for doubtful accounts -- -- -- -- -- -- Supplies and pharmaceuticals -- -- -- -- -- -- Prepaid expenses and other current assets -- -- -- -- -- -- Due from affiliated physician groups -- -- -- -- -- -- Deferred income taxes -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- TOTAL CURRENT ASSETS -- -- -- -- -- -- PROPERTY, PLANT & EQUIPMENT, at cost -- -- -- -- -- -- Less: Accumulated depreciation and amortization -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- NET PROPERTY, PLANT & EQUIPMENT -- -- -- -- -- -- OTHER ASSETS Deferred charges -- -- -- -- -- -- Less: Accumulated amortization, deferred charges -- -- -- -- -- -- Management service agreements -- -- -- -- -- -- Less: Accumulated amortization, management service agreements -- -- -- -- -- -- Other assets -- -- -- -- -- -- Intercompany receivable (payable) 28,430 25,785 25,638 25,638 24,567 24,567 -------- -------- -------- -------- -------- -------- 28,430 25,785 25,638 25,638 24,567 24,567 -------- -------- -------- -------- -------- -------- TOTAL ASSETS $ 28,430 $ 25,785 $ 25,638 $ 25,638 $ 24,567 $ 24,567 ======== ======== ======== ======== ======== ======== LIABILITIES & STOCKHOLDERS' EQUITY CURRENT LIABILITIES Post petition liabilities $ -- $ -- $ -- $ -- $ -- $ -- Pre-petition liabilities: Secured debt 29,199 26,554 26,407 26,407 25,336 25,336 Priority debt -- -- -- -- -- -- Unsecured debt: Accounts payable and accrued expenses -- -- -- -- -- -- Subordinated notes payable -- -- -- -- -- -- Capital lease obligations -- -- -- -- -- -- Other GAAP accruals not included in schedules -- -- -- -- -- -- Deferred income taxes -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- TOTAL LIABILITIES 29,199 26,554 26,407 26,407 25,336 25,336 STOCKHOLDERS' EQUITY Series A convertible preferred stock, $1.00 par value, (aggregate involuntary liquidating preference $183) authorized 3,000,000 shares issued and outstanding 16,631 shares at each period end -- -- -- -- -- -- Common stock, $.01 par value, authorized 30,000,000 shares; issued and outstanding 12,290,764 shares at each period end (1) -- -- -- -- -- -- Paid-in capital -- -- -- -- -- -- Accumulated deficit: Through filing date (769) (769) (769) (769) (769) (769) Post filing date -- -- -- -- -- -- -------- -------- -------- -------- -------- -------- (769) (769) (769) (769) (769) (769) -------- -------- -------- -------- -------- -------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 28,430 $ 25,785 $ 25,638 $ 25,638 $ 24,567 $ 24,567 ======== ======== ======== ======== ======== ========
(1) Outstanding shares at December 31, 2001, January 31, 2002 and February 28, 2002 were 12,279,555. COMPARATIVE BALANCE SHEET -----END PRIVACY-ENHANCED MESSAGE-----